Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023199	pf-leuk	E6/l (e6/l)	3343	4729	0.00%
3023199	pf-leuk	— (—)	1695	2365	100.00%	Distribution not available
3023199	pf-leuk	E6/l______ (e6/l)	113	146	0.00%
3023199	pf-leuk	E6/L (e6/l)	65	83	0.00%
3023199	pf-leuk	^9/l (e6/l)	44	45	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Heart failure and bmi 25plus

778

1024

5.26

318.51

1.5

1.4

2886.25

3686.08

e6/l

0.24

559

742

All chronic kidney diseases

1117

2479

3.68

317.73

1.6

1.4

1653.30

3603.97

e6/l

2.08

775

1785

Septicaemia

938

2177

4.05

315.73

1.6

1.4

4159.48

2655.55

e6/l

0.62

665

1556

Bacterial pneumonia, not elsewhere classified

772

1476

4.72

313.50

1.5

1.4

4006.21

2725.50

e6/l

0.40

544

1044

Diseases of the respiratory system

655

459

7.24

312.31

1.5

1.1

3413.92

1979.97

e6/l

0.52

459

305

Explicit Sepsis, including avohilmo

970

2317

3.90

310.48

1.6

1.4

4087.12

3094.55

e6/l

0.35

685

1663

Pneumonia, organism unspecified

1826

2219

5.79

307.65

1.5

1.4

4286.83

3175.54

e6/l

0.63

1266

1557

Heart failure and antihypertensive medication

619

525

7.98

307.65

1.6

1.4

3827.16

4286.51

e6/l

0.09

440

373

Non-small cell lung cancer

445

543

8.78

307.65

1.4

1.5

4220.25

2630.86

e6/l

0.35

317

396

Asthma (only as main-diagnosis), excluding more controls

534

223

13.38

307.65

1.5

1.1

2712.03

3314.99

e6/l

0.35

378

156

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1911

2343

5.56

307.65

1.5

1.4

4281.44

3135.59

e6/l

0.69

1316

1647

All-cause Heart Failure

1539

2083

5.35

307.65

1.5

1.4

2599.60

3660.59

e6/l

0.61

1087

1469

Pyothorax

484

242

27.22

307.65

1.7

1.4

17984.16

1421.97

e6/l

4.48

308

171

Oxycodone

966

1902

4.49

307.65

1.5

1.4

2946.82

2605.20

e6/l

0.14

705

1348

Pleural effusion

2182

521

59.53

307.65

1.7

1.2

2825.61

3268.69

e6/l

0.20

1606

329

Bacterial infection, other or unspecified

1282

2442

4.58

307.65

1.6

1.4

4320.47

2638.02

e6/l

0.88

918

1734

Heart failure, strict

1577

2122

5.38

307.65

1.6

1.4

2543.63

3629.94

e6/l

0.65

1117

1494

Renal tubulo-interstitial diseases

1421

3129

3.39

307.65

1.5

1.4

2570.53

3565.91

e6/l

0.82

979

2232

Renal failure

1191

2790

3.76

307.65

1.6

1.4

1961.71

3375.64

e6/l

1.41

833

2002

Other medical care

1299

2131

5.32

307.65

1.5

1.4

2735.30

2793.80

e6/l

0.03

946

1504

Other pleural conditions

1250

332

51.29

307.65

1.8

1.2

2069.48

2323.77

e6/l

0.12

1010

217

Other bacterial diseases, including avohilmo

1598

2669

3.80

307.65

1.6

1.4

4508.33

2881.33

e6/l

0.97

1103

1895

Pneumonias (Asthma/COPD co-morbidities)

1911

2308

5.54

307.65

1.5

1.4

4363.33

3103.86

e6/l

0.78

1316

1619

Heart failure, not strict

1575

1915

5.70

307.65

1.6

1.4

2714.43

4357.08

e6/l

1.02

1106

1339

Abnormal findings on diagnostic imaging of lung

1128

2933

3.76

307.65

1.5

1.4

3857.89

2759.59

e6/l

0.58

848

2033

Bacterial pneumoniae

801

1534

4.71

307.65

1.5

1.4

3929.32

2748.70

e6/l

0.38

565

1081

COPD (mode)

601

367

13.21

307.65

1.4

1.2

3229.02

1497.62

e6/l

1.70

445

232

COPD differential diagnosis

887

471

9.58

307.65

1.5

1.1

3562.51

2028.89

e6/l

0.79

620

310

Other diseases of pleura

2985

1401

21.00

307.65

1.6

1.2

2949.46

4095.72

e6/l

0.54

2241

891

Non-ischemic cardiomyopathy

826

1260

5.43

307.65

1.5

1.4

3333.75

3263.25

e6/l

0.02

573

894

All pneumoniae

1911

2303

5.52

307.65

1.5

1.4

4365.45

3112.14

e6/l

0.77

1313

1617

Malignant neoplasm of bronchus and lung

677

852

7.08

307.65

1.4

1.5

3695.32

2532.66

e6/l

0.41

495

616

Bacterial infection, other or unspecified, including avohilmo

1353

2488

4.60

307.65

1.6

1.4

4308.13

2588.45

e6/l

0.98

969

1774

1666

1906

5.23

307.65

1.5

1.4

4233.17

3010.41

e6/l

0.65

1147

1333

Any death

1623

1814

6.53

307.65

1.5

1.4

2862.23

3812.70

e6/l

0.50

1190

1176

Malignant neoplasm of respiratory system and intrathoracic organs

873

948

8.22

307.65

1.5

3334.08

2548.43

e6/l

0.33

645

679

Asthma, unspecified (mode), excluding more controls

525

215

17.73

307.65

1.5

1.1

2878.50

3301.19

e6/l

0.21

370

150

Other pulmonary diagnosis

903

467

9.83

307.65

1.5

1.1

3509.79

2042.00

e6/l

0.75

626

309

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1302

3385

3.43

307.65

1.6

1.4

3606.71

2895.35

e6/l

0.38

977

2342

Malignant neoplasm of bronchus and lung, including Hilmo

761

956

7.07

307.65

1.4

1.5

3672.19

2506.14

e6/l

0.45

538

684

Suppurative and necrotic conditions of lower respiratory tract

526

293

22.91

307.65

1.6

1.4

17495.76

1433.35

e6/l

4.82

338

209

ILD differential diagnosis

887

471

9.58

307.65

1.5

1.1

3562.51

2028.89

e6/l

0.79

620

310

Lung cancer and mesothelioma

898

269

31.03

307.65

1.5

1.1

3346.43

1170.48

e6/l

1.57

650

167

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

957

1041

8.13

307.65

1.5

3356.15

2417.32

e6/l

0.46

689

750

Excluding asthma or asthma-COPD overlap

888

467

9.67

307.65

1.5

1.1

3556.02

2042.00

e6/l

0.78

621

309

Persons encountering health services for specific procedures and health care

1502

2639

3.41

307.65

1.5

1.4

4165.08

3427.09

e6/l

0.32

1050

1852

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1666

1906

5.23

307.65

1.5

1.4

4233.17

3010.41

e6/l

0.65

1147

1333

Non-small cell lung cancer, including Hilmo

591

752

7.92

307.65

1.4

1.5

3835.56

2648.39

e6/l

0.34

413

545

Later onset COPD, excluding more controls

440

301

11.59

307.65

1.5

1.1

2617.42

1359.74

e6/l

1.38

321

191

Asthma, unspecified (mode)

551

453

8.90

307.65

1.5

1.1

3416.17

2020.15

e6/l

1.10

390

299

Bacterial Sepsis

1094

2368

3.94

307.65

1.6

1.4

3860.42

3080.35

e6/l

0.30

790

1702

Influenza and pneumonia

1857

2236

5.24

307.65

1.5

1.4

4230.02

3168.87

e6/l

0.60

1285

1570

Heart failure,strict

1412

1572

6.54

307.65

1.6

1.4

2628.08

4138.68

e6/l

0.79

1002

1098

Other bacterial diseases

1662

2849

3.94

307.65

1.5

1.4

4252.28

2872.44

e6/l

0.82

1154

2011

Dyspnoea

1658

3197

3.82

307.65

1.6

1.4

2970.44

3379.22

e6/l

0.26

1229

2192

Asthma, excluding more controls

584

223

13.59

307.65

1.5

1.1

2692.69

3314.99

e6/l

0.37

402

156

Non-small cell lung cancer, adenocarcinoma

314

279

12.61

306.34

1.5

1.4

2516.86

1385.46

e6/l

1.83

226

195

Explicit Sepsis

956

2298

3.90

305.79

1.6

1.4

4120.58

3106.76

e6/l

0.36

676

1650

Asthma

636

465

7.13

304.94

1.5

1.1

2572.42

2036.59

e6/l

0.56

444

308

Implicit bacterial Sepsis

980

2236

3.88

304.75

1.6

1.4

4039.15

3140.43

e6/l

0.33

722

1610

Implicit bacterial Sepsis, including avohilmo

1028

2343

3.76

303.60

1.6

1.4

3996.07

3091.56

e6/l

0.34

744

1681

Heart failure and coronary heart disease

1056

2073

3.70

286.74

1.6

1.5

1814.08

3331.68

e6/l

1.35

755

1469

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1450

3349

2.96

280.71

1.5

1.4

3209.27

3338.43

e6/l

0.05

1019

2362

Implicit Sepsis

1234

2886

3.21

279.30

1.5

1.4

4075.82

3017.08

e6/l

0.48

888

2046

Asthma (only as main-diagnosis)

568

465

6.90

277.92

1.5

1.1

3191.73

2036.59

e6/l

0.93

403

308

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

191

31.72

277.47

2.0

1.4

1866.56

1703.24

e6/l

0.14

147

Abnormalities of breathing

1201

2060

3.38

272.49

1.6

1.4

2563.96

3245.71

e6/l

0.53

883

1397

Other septicaemia, including avohilmo

844

2092

3.90

272.34

1.6

1.4

4393.79

2688.01

e6/l

0.65

604

1503

Malignant neoplasm of heart, mediastinum and pleura

171

42.46

267.86

2.0

1.3

1783.56

2155.95

e6/l

0.29

135

Other septicaemia

830

2069

3.90

267.82

1.6

1.4

4445.26

2655.43

e6/l

0.68

594

1486

Asthma (mode)

582

471

6.55

264.28

1.5

1.1

2932.56

2028.89

e6/l

0.95

416

310

All kidney diseases

1341

3062

2.97

261.40

1.5

1.4

2625.49

3919.75

e6/l

1.12

923

2174

Dialysis, with operation codes

406

607

7.14

260.70

1.7

1.4

1507.75

3867.29

e6/l

0.93

305

431

Other heart diseases, wide

1018

1733

3.60

258.31

1.5

1.4

2349.95

4295.93

e6/l

1.69

699

1208

Other heart diseases

526

568

6.11

250.27

1.5

1.3

2427.03

3873.06

e6/l

0.94

372

404

Mesothelioma, including Hilmo

163

40.17

250.23

2.1

1.3

1616.78

2075.29

e6/l

0.39

130

Early onset COPD, excluding more controls

268

251

10.92

248.16

1.4

1.2

4958.35

2163.85

e6/l

0.86

190

155

Implicit Sepsis, including avohilmo

1207

2927

2.99

241.83

1.6

1.4

4056.69

3107.86

e6/l

0.41

871

2067

Mesothelioma

154

46.90

241.22

2.1

1.3

1651.34

2027.03

e6/l

0.29

123

Nephropathy related operations

388

619

6.69

234.21

1.7

1.4

1217.27

4047.88

e6/l

1.28

289

442

Other diseases of pericardium

200

133

16.67

231.20

1.6

1.2

1666.54

9295.29

e6/l

0.61

147

Chronic kidney disease

801

2217

3.60

230.29

1.6

1.4

1731.34

3183.14

e6/l

1.21

567

1590

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

251

250

10.92

225.53

1.8

1.4

1398.86

1525.48

e6/l

0.22

187

172

Valvular heart disease excluding rheumatic fever

728

1328

4.00

224.67

1.6

1.4

2770.99

3875.18

e6/l

0.56

534

940

Non-small cell lung cancer, adenocarcinoma, helper endpoint

314

423

8.27

223.74

1.5

1.4

2516.86

3975.50

e6/l

0.30

226

286

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

523

1090

4.82

223.74

1.4

1.5

2034.01

2435.99

e6/l

0.37

371

772

Acute renal failure

590

1419

4.34

221.77

1.6

1.4

2534.39

3279.13

e6/l

0.33

431

1013

Non-rheumatic valve diseases

720

1327

3.95

218.91

1.6

1.4

2713.14

3877.79

e6/l

0.60

530

939

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

434

824

5.49

217.12

1.4

1.5

2143.65

2362.37

e6/l

0.13

321

579

Condition for Implicit Sepsis (Organ dysfunction codes)

1173

2884

2.86

215.29

1.6

1.4

4142.06

3174.96

e6/l

0.40

845

2037

Malignant neoplasm

1000

1830

3.24

215.13

1.5

3358.01

4160.46

e6/l

0.30

689

1291

Malignant neoplasm of mesothelium and soft tissue

202

157

14.52

214.51

1.9

1.5

1492.12

1696.94

e6/l

0.28

153

105

COPD/asthma/ILD related infections

1152

1906

3.06

214.38

1.5

1.4

3174.78

3010.41

e6/l

0.07

798

1333

COPD/asthma related infections

1152

1906

3.06

214.38

1.5

1.4

3174.78

3010.41

e6/l

0.07

798

1333

Anaemias

232

18.19

212.98

1.6

1.3

2938.81

4931.66

e6/l

0.63

159

Malignant neoplasm

995

1829

3.23

212.56

1.5

3380.34

4161.27

e6/l

0.29

686

1290

Malignant neoplasm, wide definition

994

1839

3.18

207.72

1.5

3409.37

4158.32

e6/l

0.27

678

1299

Malignant neoplasm, including Hilmo

991

1833

3.19

207.39

1.5

3402.43

4160.31

e6/l

0.28

676

1295

Solid cancers

971

1813

3.18

202.83

1.5

3225.53

4162.30

e6/l

0.36

667

1282

Liquid cancers, including Hilmo

619

1414

3.95

201.17

1.5

1.4

2223.80

3522.96

e6/l

0.89

454

1013

Solid cancers, including Hilmo

972

1830

3.13

198.00

1.5

3266.61

4154.78

e6/l

0.33

662

1291

Fever of other and unknown origin

853

2378

3.16

197.65

1.5

1.4

4108.10

3201.96

e6/l

0.28

619

1671

Atrial fibrillation and flutter

425

471

5.94

195.93

1.5

1.3

1347.09

3654.23

e6/l

5.52

300

338

Any event in cancer register

1004

1953

3.04

194.71

1.5

3721.92

4025.66

e6/l

0.09

692

1367

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1120

2779

2.75

191.19

1.5

1.4

5126.57

2903.08

e6/l

0.96

799

1970

Care involving dialysis

250

308

8.68

190.43

1.7

1.4

1010.39

2012.98

e6/l

1.65

182

217

Non-invasive ventilation

368

558

5.81

188.26

1.5

1.4

3755.91

3348.61

e6/l

0.14

315

387

Erysipelas, including avohilmo

995

2612

2.86

186.88

1.5

1.4

3273.89

2798.52

e6/l

0.18

683

1853

GASTRO-related operations

745

1013

3.72

184.73

1.5

1.4

3466.69

5001.19

e6/l

0.46

516

676

Any gastric operation

745

1013

3.72

184.73

1.5

1.4

3466.69

5001.19

e6/l

0.46

516

676

Bacterial pneumonia (organism specified)

840

2557

3.04

183.43

1.5

3765.24

2724.89

e6/l

0.36

596

1808

Cardiomyopathy

354

653

5.61

182.37

1.6

1.4

4540.59

4377.88

e6/l

0.02

238

460

Pneumothorax

195

183

11.32

181.84

1.7

1.2

5815.91

1437.18

e6/l

1.00

148

118

Continuous positive airway pressure

333

478

5.97

171.71

1.5

1.4

2610.17

3321.56

e6/l

0.23

241

339

Aplastic and other anaemias

876

2990

2.74

158.44

1.5

3559.98

2716.27

e6/l

0.28

597

2146

Diseases of arteries, arterioles and capillaries (FINNGEN)

335

402

5.87

157.53

1.6

1.3

1388.79

3736.45

e6/l

4.63

229

293

Atrial fibrillation and flutter with reimbursement

360

416

5.57

154.42

1.5

1.3

1866.46

3737.20

e6/l

2.55

252

301

Ascites

253

401

6.74

153.96

1.6

1.4

1772.88

3992.08

e6/l

0.49

189

285

Non-allergic asthma (mode), excluding more controls

140

104

13.51

148.43

1.5

1.1

3136.46

2694.95

e6/l

0.16

Erysipelas

803

2543

2.76

146.95

1.5

1.4

3278.31

2864.45

e6/l

0.13

557

1802

Liquid cancers

485

1276

3.68

145.65

1.6

1.5

2436.40

3207.23

e6/l

0.39

346

914

First line medication for Crohn's disease

1240

2873

2.34

143.84

1.6

1.4

3172.14

3541.47

e6/l

0.17

893

1992

Other anaemias

804

2895

2.65

137.57

1.5

3781.80

2723.40

e6/l

0.33

541

2080

Other and unspecified anaemias

795

2885

2.64

134.80

1.5

3819.96

2731.09

e6/l

0.34

534

2073

Cardiac arrhythmias

545

1017

3.47

134.71

1.5

1.4

2986.27

3868.80

e6/l

0.36

383

720

Cardiomyopathy (excluding other)

252

471

5.55

128.33

1.5

1.3

5860.84

5017.84

e6/l

0.07

174

327

Extracorporeal dialysis

200

311

6.92

124.26

1.7

1.4

675.74

4529.44

e6/l

0.76

147

215

Cardiomyopathies, Primary/intrinsic

241

447

5.59

123.77

1.5

1.3

6085.62

5080.75

e6/l

0.08

166

311

Hypertensive heart and/or renal disease

518

1174

3.31

122.38

1.6

1.4

1526.58

4021.00

e6/l

1.69

354

834

Secondary uncertain malignant neoplasm

274

581

4.88

120.72

1.5

1716.12

2363.42

e6/l

0.60

208

409

COPD

787

2588

2.52

117.47

1.4

1.5

3086.47

2560.85

e6/l

0.33

564

1815

Presence of cardiac and vascular implants and grafts

801

2396

2.51

115.71

1.5

1406.59

3475.03

e6/l

2.72

587

1673

Implicit viral Sepsis, including avohilmo

505

1673

3.08

115.65

1.6

1.4

2501.29

3560.66

e6/l

0.48

350

1203

Valvular operations

263

559

4.85

115.38

1.6

1.3

3588.54

4457.41

e6/l

0.15

188

397

Respiratory insufficiency

133

138

9.91

114.56

1.6

1.2

3082.08

1184.16

e6/l

1.18

107

Malaise and fatigue

715

2210

2.58

112.37

1.5

1.4

2788.82

2846.68

e6/l

0.02

502

1553

Tramadol

867

2170

2.43

112.09

1.6

1.4

2584.78

3056.20

e6/l

0.38

570

1537

Unspecified kidney failure

277

637

4.55

110.86

1.6

1.4

1461.60

3341.24

e6/l

0.73

181

460

Other chronic obstructive pulmonary disease

757

2539

2.49

110.39

1.4

1.5

2958.77

2569.44

e6/l

0.22

547

1780

malignant neoplasm of female genital organs, including Hilmo

243

471

5.04

110.27

1.3

1.4

1382.17

1941.21

e6/l

0.77

162

329

ILD medications: prednisolone, methylprednisolone, prednisone

1200

3200

2.10

108.97

1.6

1.4

2618.11

3595.09

e6/l

0.95

865

2235

Diseases of arteries, arterioles and capillaries

981

3286

2.22

108.50

1.5

1866.78

3470.85

e6/l

2.30

673

2338

Acute tubulo-interstitial nephritis

786

2800

2.40

107.56

1.5

1.4

3278.95

3405.88

e6/l

0.05

551

2021

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

276

649

4.38

106.75

1.5

1692.01

2553.00

e6/l

0.95

210

457

Complications of surgical and medical care, not elsewhere classified

1167

3794

2.07

106.62

1.5

3460.91

3213.45

e6/l

0.09

826

2661

AV-block

314

670

4.10

106.61

1.6

1.4

2154.14

3951.33

e6/l

0.63

227

482

Conduction disorders

412

984

3.41

106.17

1.6

1.4

1960.78

3627.28

e6/l

0.91

285

707

Certain infectious and parasitic diseases

941

2046

2.32

105.15

1.5

1.4

3346.13

3230.07

e6/l

0.04

644

1449

Cerebrovascular diseases (FINNGEN)

299

481

4.41

104.97

1.6

1.3

3774.52

3641.00

e6/l

0.03

211

345

Other disorders of fluid, electrolyte and acid-base balance

557

1927

2.78

104.73

1.6

1.4

6382.53

2312.73

e6/l

1.18

418

1360

Hypertensive Heart Disease

462

1126

3.19

104.44

1.6

1.4

1645.50

4010.95

e6/l

1.45

317

801

Implicit viral Sepsis

373

1099

3.48

104.40

1.6

1.4

1739.06

3231.63

e6/l

1.01

267

794

Viral Sepsis

373

1099

3.48

104.40

1.6

1.4

1739.06

3231.63

e6/l

1.01

267

794

Haemorrhage from respiratory passages

527

1656

2.87

103.88

1.5

1.4

2642.10

2769.83

e6/l

0.06

380

1127

Oral corticosteroids

1188

3430

2.05

102.24

1.6

1.4

2604.16

3544.99

e6/l

0.97

869

2392

Glomerular diseases

346

1006

3.54

99.16

1.6

1.5

1403.03

3270.20

e6/l

1.26

251

699

Transplanted organ and tissue status

200

384

5.41

99.05

1.6

1.4

1844.55

4804.42

e6/l

0.65

135

268

Malignant neoplasm of ovary, including Hilmo

126

150

8.78

98.34

1.3

1.5

1468.61

2188.34

e6/l

0.36

108

Pulmonary heart disease, diseases of pulmonary circulation

559

2143

2.66

98.00

1.5

1912.41

3008.57

e6/l

1.17

385

1503

Other chronic obstructive pulmonary disease, including avohilmo

837

3108

2.25

97.50

1.4

1.5

3060.31

2981.72

e6/l

0.04

605

2187

Glomerular disorders in diseases classified elsewhere

260

629

4.30

97.30

1.7

1.4

1362.70

3525.39

e6/l

0.85

191

442

Cardiovascular diseases (excluding rheumatic etc)

380

600

3.65

97.20

1.5

1.3

2896.68

4537.19

e6/l

1.06

252

424

COPD, early/later onset

766

2813

2.33

97.12

1.4

1.5

3309.31

2980.98

e6/l

0.15

553

1976

Undetermined asthma, excluding more controls

12.89

96.36

1.5

1.1

4936.29

2532.53

e6/l

0.83

ILD medications

1190

3210

2.01

95.89

1.6

1.4

2575.32

3598.59

e6/l

1.02

851

2240

All influenza

336

978

3.49

95.50

1.6

1.4

1395.06

3074.71

e6/l

1.13

247

689

Other arrhythmias

571

1616

2.66

94.81

1.5

1.4

3257.64

4143.98

e6/l

0.35

408

1135

Pericarditis

11.70

94.39

1.4

1.3

1901.75

12309.98

e6/l

0.51

COPD, hospital admissions

755

2804

2.31

94.15

1.4

1.5

3359.93

2960.12

e6/l

0.19

543

1975

malignant neoplasm of female genital organs

212

436

4.87

93.43

1.3

1.4

1340.24

1907.53

e6/l

0.72

145

306

Codes for special purposes

700

3015

2.33

92.91

1.5

4128.70

2526.07

e6/l

0.67

447

2141

Provisional assignment of new diseases of uncertain etiology

699

3014

2.33

92.56

1.5

4135.73

2526.19

e6/l

0.67

446

2141

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1026

3167

2.06

91.95

1.5

2660.61

3888.63

e6/l

1.10

741

2194

COPD related to multimorbidity

702

2564

2.36

91.90

1.5

3378.38

3070.01

e6/l

0.13

513

1798

Covid-19 confirmed case

595

2419

2.50

91.89

1.5

3727.02

2626.72

e6/l

0.39

373

1734

Bleeding

1029

3572

2.04

91.39

1.5

1.4

3671.36

3034.08

e6/l

0.25

732

2499

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

13.48

89.94

1.4

1783.15

1343.40

e6/l

0.33

Opioids

921

2201

2.18

89.69

1.5

1.4

3090.70

3123.99

e6/l

0.01

621

1557

Complications of procedures, not elsewhere classified

944

3713

2.07

89.58

1.5

3661.05

3162.00

e6/l

0.17

684

2606

Symptoms and signs involving the circulatory and respiratory systems

899

2061

2.20

89.16

1.5

1.4

3070.81

3245.71

e6/l

0.06

641

1397

Allergic asthma (mode), excluding more controls

100

10.23

88.30

1.4

1.1

2736.46

2700.44

e6/l

0.02

Diabetic nephropathy, excluding more controls

298

668

3.76

87.70

1.6

1.4

1187.83

3435.27

e6/l

2.24

212

440

Hypertensive diseases (excluding secondary)

347

567

3.59

87.35

1.5

1.3

4852.50

3883.78

e6/l

0.15

242

404

Inflammatory bowel disease treatment related agents

1193

3449

1.93

86.50

1.6

1.4

2595.17

3561.72

e6/l

1.01

858

2400

Infections, IBD-co-morbidities

247

407

4.35

85.01

1.6

1.4

3108.36

3341.88

e6/l

0.04

189

280

Pleural plaque

180

362

5.16

84.62

1.4

1.2

3499.47

3392.14

e6/l

0.02

152

235

Pulmonary embolism

496

1935

2.62

84.00

1.5

2037.84

3177.98

e6/l

1.07

336

1360

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

311

537

3.68

83.53

1.5

1.3

2680.36

3640.56

e6/l

0.61

210

385

Viral pneumonia

203

457

4.56

83.00

1.6

1.4

2214.88

4114.88

e6/l

0.45

146

332

Asthma-related pneumonia

575

2407

2.42

82.89

1.5

2873.51

2741.46

e6/l

0.08

400

1695

Non-allergic asthma (mode)

140

223

6.29

82.68

1.5

1.2

3136.46

1348.57

e6/l

1.10

143

Asthma, hospital admissions 3, pneumonia

575

2410

2.42

82.65

1.5

2873.52

2738.03

e6/l

0.08

400

1698

Asthma-related pneumonia or sepsis

575

2410

2.42

82.65

1.5

2873.51

2738.03

e6/l

0.08

400

1698

DVT of lower extremities and pulmonary embolism

636

2786

2.31

82.38

1.4

1.5

2078.41

2861.47

e6/l

0.89

438

1965

COPD, hospital admissions 3, with asthma pneumonia sepsis

533

1835

2.55

82.38

1.4

1.5

2992.04

2424.76

e6/l

0.28

383

1285

Percutaneous Coronary Intervention

888

2599

2.10

82.27

1.5

1.4

4037.20

3557.75

e6/l

0.15

629

1826

Pulmonary heart disease

496

1955

2.59

82.25

1.5

2037.84

3147.33

e6/l

1.04

336

1378

Any reimbursement code in KELA

335

461

3.66

81.97

1.5

1.3

2759.90

5291.12

e6/l

0.99

224

325

Malignant neoplasm of digestive organs, including Hilmo

521

1493

2.60

81.96

1.4

2218.64

3411.68

e6/l

0.72

367

1058

Peripheral artery disease

733

2658

2.22

81.91

1.5

1459.21

3342.87

e6/l

2.58

525

1917

COPD, hospital admission 2, with asthma infections

585

2118

2.43

81.88

1.4

1.5

2938.38

2374.10

e6/l

0.32

418

1486

General symptoms and signs

1011

2513

2.03

81.83

1.5

1.4

2640.02

3233.03

e6/l

0.42

711

1753

Venous thromboembolism

761

3475

2.14

81.17

1.5

3350.25

2756.22

e6/l

0.25

529

2450

Emergency coronary revascularization (for ACS)

993

3024

2.00

80.98

1.5

1.4

3809.42

3484.34

e6/l

0.11

698

2129

Paroxysmal tachycardia

214

406

4.44

80.54

1.5

1.3

1596.40

3573.80

e6/l

3.19

152

298

L04AD Calcineurin inhibitors

182

385

4.88

80.49

1.7

1.4

1281.39

4614.03

e6/l

0.88

123

281

Explicit bacterial Sepsis, including avohilmo

213

513

4.28

80.01

1.6

1.4

6671.98

3692.96

e6/l

0.26

142

373

Malignant neoplasm of breast, HER2-negative

331

634

3.40

79.99

1.3

1.4

3892.58

3316.31

e6/l

0.10

237

439

Malignant neoplasm of breast

330

634

3.39

79.36

1.3

1.4

3892.58

3316.31

e6/l

0.10

237

439

Complications of medical and surgical care

868

3914

2.01

78.17

1.5

1.4

3821.06

3099.86

e6/l

0.24

617

2756

Metabolic disorders

992

3036

1.97

78.12

1.5

1.4

4470.61

2786.21

e6/l

0.67

666

2160

L01XE Protein kinase inhibitors

150

278

5.75

77.94

1.5

1659.72

4930.99

e6/l

0.51

118

189

Malignant neoplasm of breast, HER2-negative, including Hilmo

330

638

3.35

77.67

1.3

1.4

3875.70

3312.49

e6/l

0.10

237

442

Malignant neoplasm of breast, including Hilmo

330

638

3.35

77.65

1.3

1.4

3875.70

3312.49

e6/l

0.10

237

442

Explicit bacterial Sepsis

209

508

4.25

77.58

1.6

1.4

6702.50

3699.02

e6/l

0.26

141

372

Coronary revascularization (ANGIO or CABG)

872

2599

2.06

76.80

1.5

1.4

4096.67

3557.75

e6/l

0.17

616

1826

Caries of dentine

360

1210

2.92

75.19

1.6

1.5

5653.78

2635.76

e6/l

0.53

244

845

Dental caries

391

1344

2.79

74.81

1.6

1.5

5437.14

2722.71

e6/l

0.51

264

949

Neoplasms

558

1184

2.49

73.62

1.5

1.4

4332.60

5329.63

e6/l

0.21

380

832

Ulcer of lower limb, not elsewhere classified

305

992

3.17

73.13

1.6

1.5

2344.20

2849.14

e6/l

0.18

200

699

Pacemaker

635

2717

2.21

73.01

1.5

1336.01

2920.80

e6/l

2.69

457

1924

Serous carcinoma of ovary, including Hilmo

10.88

72.72

1.2

1.4

1617.29

1199.78

e6/l

0.36

Malignant neoplasm of digestive organs

476

1448

2.55

72.67

1.4

2244.27

3434.86

e6/l

0.67

338

1030

Atherosclerosis, excluding cerebral and coronary sclerosis

694

2571

2.16

72.52

1.5

1292.45

3352.02

e6/l

2.98

495

1857

Malignant neoplasm of breast, HER-positive

278

604

3.47

72.41

1.4

3650.03

3361.18

e6/l

0.04

196

419

Malignant neoplasm of breast, ER-positive, including Hilmo

278

604

3.46

72.25

1.4

3650.03

3361.18

e6/l

0.04

196

419

Hyperkalaemia

161

342

4.95

71.38

1.6

1.4

929.75

2105.67

e6/l

2.23

110

246

Major coronary heart disease event

912

2804

1.96

70.47

1.5

1.4

3943.94

3604.83

e6/l

0.11

646

1972

Other CVD (FINNGEN)

167

258

5.05

70.43

1.7

1.3

14570.16

2673.27

e6/l

0.96

121

192

Dialysis

101

139

7.69

70.07

1.7

1.4

551.61

2206.20

e6/l

3.67

Streptococcal septicaemia, including avohilmo

190

468

4.20

69.47

1.6

1.4

7132.55

2285.53

e6/l

0.45

130

335

Adjustment and management of implanted device

319

1096

2.98

69.27

1.6

1.4

1400.30

3000.00

e6/l

1.53

165

775

Malignant neoplasm of ovary

112

8.48

69.17

1.2

1.5

1494.01

1221.42

e6/l

0.27

Streptococcal septicaemia

186

453

4.25

69.05

1.6

1.4

7169.49

2262.88

e6/l

0.45

129

326

Hard cardiovascular diseases

837

2481

2.01

68.97

1.5

4168.71

3804.97

e6/l

0.10

592

1728

Cardiovascular diseases

313

501

3.33

68.79

1.5

1.3

3282.08

4121.21

e6/l

0.50

212

353

Pain in throat and chest

727

2050

2.11

68.59

1.5

1.4

4942.75

3247.09

e6/l

0.43

506

1387

ILD medications: immunosuppressive drugs

637

2712

2.14

68.50

1.5

1.4

3125.58

3934.22

e6/l

0.50

436

1877

Secondary hypertension

120

199

6.10

67.87

1.5

1.3

995.29

2962.52

e6/l

4.26

137

Secondary and unspecified malignant neoplasm of lymph nodes

151

322

4.85

66.29

1.7

1.5

1734.60

2166.24

e6/l

0.25

107

223

Hernia of abdominal wall, postoperative

199

518

3.87

66.09

1.4

4185.06

4191.32

e6/l

0.00

141

346

Ischemic heart diseases

853

2621

1.95

65.08

1.5

1.4

4148.96

3566.79

e6/l

0.18

595

1842

Oedema, not elsewhere classified

428

1713

2.47

64.91

1.6

1.4

1897.01

2586.60

e6/l

0.50

292

1193

Cardiomyopathy, other and unspecified

130

250

5.37

64.31

1.6

1.3

8744.36

6009.66

e6/l

0.12

172

Iron deficiency anaemia

589

2723

2.15

64.22

1.5

1.4

4283.56

3001.29

e6/l

0.31

425

1909

Abscess of lung

11.65

64.12

1.4

1.3

17351.46

1686.69

e6/l

1.05

Polyarthropathies

791

2590

1.98

63.72

1.5

1.4

2404.40

3662.90

e6/l

1.15

542

1826

Non-Hodgkin lymphoma, all, including Hilmo

204

561

3.73

63.69

1.6

1.5

1978.37

2586.96

e6/l

0.49

145

400

Calcific aortic valvular stenosis, operated

536

2370

2.22

62.57

1.6

1.4

1527.19

2781.58

e6/l

1.43

389

1668

Calcific aortic valvular stenosis

536

2370

2.22

62.57

1.6

1.4

1527.19

2781.58

e6/l

1.43

389

1668

Other respiratory disorders and diseases

365

1423

2.62

62.24

1.6

1.5

3774.56

2775.50

e6/l

0.36

287

992

Other diseases of the respiratory system

365

1423

2.62

62.24

1.6

1.5

3774.56

2775.50

e6/l

0.36

287

992

Malignant neoplasm of other and unspecified female genital organs

15.84

62.08

1.4

1572.36

1130.25

e6/l

0.52

Operations 2 for CAVS

534

2370

2.21

61.76

1.6

1.4

1528.71

2781.58

e6/l

1.43

388

1668

Calcific aortic valvular stenosis, diagnosis (helper)

534

2370

2.21

61.76

1.6

1.4

1528.71

2781.58

e6/l

1.43

388

1668

Primary_lymphoid and hematopoietic malignant neoplasms

393

1593

2.52

61.70

1.6

1.5

2636.37

3423.55

e6/l

0.42

283

1122

Insulin medication

730

3103

1.97

61.29

1.6

1.4

1673.27

3241.91

e6/l

2.56

523

2186

Calcific aortic valvular stenosis, including rheumatic fever

534

2378

2.20

61.06

1.6

1.4

1528.71

2775.31

e6/l

1.42

388

1673

Codeine

789

2184

1.96

59.95

1.5

1.4

3086.15

3142.08

e6/l

0.02

539

1541

Nutritional anaemias

661

3198

1.99

58.63

1.5

1.4

3939.01

2775.63

e6/l

0.32

481

2250

Preparatory care for dialysis

121

240

5.35

58.38

1.6

1.5

1405.78

5378.16

e6/l

0.53

164

Endocarditis

101

8.20

58.28

1.6

1.2

7081.14

11121.96

e6/l

0.16

Diabetic nephropathy

302

1095

2.80

58.11

1.6

1.5

1185.32

3757.17

e6/l

1.37

215

753

Major coronary heart disease event excluding revascularizations

729

2494

1.95

56.51

1.5

3965.73

3670.24

e6/l

0.07

504

1756

Care involving use of rehabilitation procedures

574

2517

2.07

56.08

1.4

5291.58

3344.67

e6/l

0.51

414

1771

STROKE

536

1695

2.15

54.40

1.5

1.4

1979.15

3490.30

e6/l

1.90

385

1171

Type 2 diabetes, wide definition

848

2939

1.83

54.34

1.5

1.4

3344.52

3190.15

e6/l

0.04

574

2093

Undetermined asthma

152

6.18

54.28

1.5

1.2

4936.29

1411.24

e6/l

1.57

Coronary atherosclerosis

731

2425

1.92

53.76

1.5

1.4

3246.51

3598.47

e6/l

0.10

512

1704

Other disorders of skin and subcutaneous tissue

826

3887

1.81

53.56

1.5

3606.53

2884.50

e6/l

0.31

585

2741

Hypertension, essential

637

1790

2.02

53.30

1.5

1.4

3241.88

4500.59

e6/l

0.36

435

1273

Nonischemic cardiomyopathy

183

529

3.56

53.14

1.5

1.4

9426.31

2297.40

e6/l

0.66

121

370

Malignant neoplasm of skin, including Hilmo

507

1576

2.17

53.01

1.4

2364.28

3653.89

e6/l

0.91

340

1117

Amputation

208

654

3.28

52.96

1.6

1.4

2441.69

3380.15

e6/l

0.25

144

471

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

693

3636

1.89

52.66

1.5

3816.03

2962.44

e6/l

0.24

502

2556

Certain infectious and parasitic diseases, including avohilmo

637

1575

2.04

52.63

1.6

1.4

3756.64

3239.56

e6/l

0.13

432

1137

Malignant neoplasm of skin

494

1542

2.19

52.61

1.4

2260.13

3416.70

e6/l

0.82

338

1090

Hypothyroidism (congenital or acquired)

109

6.67

52.52

1.6

1.3

1849.88

4997.96

e6/l

2.20

Lung transplantation

23.66

52.25

1.6

1.5

2138.20

1667.91

e6/l

0.23

Hypothyroidism, levothyroxine purchases

107

6.70

51.78

1.6

1.3

1924.38

4960.62

e6/l

2.00

Hypothyroidism and >3 levothyroxin purchases

107

6.70

51.78

1.6

1.3

1924.38

4960.62

e6/l

2.00

Later onset COPD

510

1963

2.13

51.73

1.5

2411.33

2274.08

e6/l

0.07

374

1368

Myocardial infarction

610

2154

2.00

51.67

1.5

4094.26

3691.67

e6/l

0.09

433

1520

Gout

478

1934

2.16

51.18

1.6

1.4

1706.75

3795.31

e6/l

1.89

323

1388

Non-small cell lung cancer, squamous

114

240

4.95

51.07

1.4

1.5

8860.25

2308.98

e6/l

0.44

169

Allergic asthma (mode)

100

181

5.42

50.72

1.4

1.2

2736.46

1654.16

e6/l

0.99

118

Hypertensive diseases

635

1812

1.99

50.65

1.5

1.4

3333.51

4502.02

e6/l

0.33

438

1286

Lung transplant status

22.98

50.33

1.6

1.5

2138.20

1667.91

e6/l

0.23

Hypertension

634

1812

1.98

50.33

1.5

1.4

3340.33

4502.02

e6/l

0.32

437

1286

Gout, FINNGEN

478

2281

2.12

50.11

1.6

1.5

1706.75

3059.83

e6/l

1.36

323

1634

Chronic lower respiratory diseases

1117

3539

1.67

50.11

1.5

3833.93

3136.51

e6/l

0.31

791

2469

Insulin, combination of fast acting with intermediate-acting or long-acting

731

3666

1.82

49.44

1.6

1.4

1670.77

3273.96

e6/l

2.68

524

2590

ILD, hospital admissions 3, with pneumonia sepsis

148

392

3.89

49.01

1.5

1.4

5264.92

4203.44

e6/l

0.12

286

Peripheral arterial reconstruction

323

1334

2.48

49.01

1.5

1274.80

2364.37

e6/l

1.69

235

945

Other dialysis

137

6.45

48.74

1.8

1.4

523.23

2184.68

e6/l

3.46

Other and unspecified iron deficiency

446

2105

2.14

48.58

1.6

1.4

5095.92

3106.53

e6/l

0.37

308

1476

Asthma, hospital admission 2, infections

647

3395

1.87

48.26

1.4

1.5

2846.79

3323.46

e6/l

0.34

450

2388

Asthma-related infections

647

3395

1.87

48.26

1.4

1.5

2846.79

3323.46

e6/l

0.34

450

2388

L04AA Selective immunosuppressants

254

943

2.73

47.68

1.7

1.5

2875.88

3279.43

e6/l

0.13

166

650

Hypo-osmolality and hyponatraemia

282

1096

2.60

47.62

1.6

1.5

5669.08

2422.95

e6/l

0.83

227

776

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

471

1502

2.14

47.25

1.4

2309.22

3413.49

e6/l

0.73

313

1066

Enterocolitis due to Clostridium difficile

197

642

3.15

47.22

1.6

1.4

3074.94

3433.30

e6/l

0.06

156

447

Hypothyroidism, drug reimbursement

8.58

47.22

1.6

1.3

2498.47

4862.93

e6/l

0.70

Basal cell carcinoma, including Hilmo

463

1475

2.15

47.04

1.4

2361.15

3409.23

e6/l

0.67

307

1051

Type 1 diabetes

274

1069

2.59

46.36

1.6

1.5

1255.37

2813.58

e6/l

2.68

203

759

COPD-related respiratory insufficiency

227

811

2.88

46.26

1.4

1.5

4374.02

2803.61

e6/l

0.34

168

559

Other bacterial intestinal infections

265

1027

2.63

45.80

1.6

1.5

2682.39

2966.43

e6/l

0.06

213

719

Insulin, fast-acting

426

2028

2.12

45.55

1.7

1.4

1535.70

2944.19

e6/l

1.70

305

1413

ILD, hospital admission 2, with pulmonary infections

154

442

3.57

45.27

1.5

1.4

5127.98

4122.96

e6/l

0.12

314

Insulin, intermediate and long-acting

648

3451

1.83

44.64

1.6

1.4

1592.06

3392.87

e6/l

2.96

465

2442

Other malignant neoplasms of skin (=non-melanoma skin cancer)

454

1472

2.11

44.42

1.4

2220.85

3400.84

e6/l

0.79

305

1048

Autoimmune diseases excluding thyroid diseases

1002

3288

1.66

44.31

1.5

1.4

2882.13

3327.47

e6/l

0.31

733

2287

Kidney transplant status

180

5.24

43.80

1.7

1.4

944.40

2200.55

e6/l

2.52

125

Basal cell carcinoma

444

1447

2.11

43.45

1.4

2333.72

3408.40

e6/l

0.67

298

1032

Diseases of oesophagus, stomach and duodenum

1006

3636

1.64

43.45

1.5

1.4

4021.56

3161.42

e6/l

0.36

706

2561

Intestinal infectious diseases

910

4086

1.66

43.37

1.5

1.4

2565.95

3470.94

e6/l

0.73

657

2863

Disorders of lipoprotein metabolism and other lipidaemias

829

2938

1.73

43.34

1.5

1.4

3755.55

2784.41

e6/l

0.36

553

2098

Peripheral artery operations in Hilmo

230

857

2.75

43.15

1.6

1.4

2288.51

3495.65

e6/l

0.43

160

618

Malignant neoplasm of urinary organs, including Hilmo

167

523

3.27

42.75

1.5

1308.59

2372.48

e6/l

1.10

111

378

Autoimmune diseases excluding thyroid diseases, strict definition

965

3185

1.66

42.39

1.5

1.4

2906.46

3388.75

e6/l

0.32

709

2218

Dilated cardiomyopathy

209

750

2.86

42.28

1.5

6903.56

3040.73

e6/l

0.36

144

523

Anaemia in chronic diseases classified elsewhere

123

6.34

42.08

1.5

1.4

1445.70

2195.39

e6/l

0.60

Bacterial intestinal infections, IBD co-morbidities

262

1059

2.52

41.54

1.6

1.5

2713.16

2917.46

e6/l

0.04

210

738

Amputation of toe

153

465

3.41

41.43

1.6

1.5

2317.14

3551.90

e6/l

0.26

107

332

Implicit fungal Sepsis, including avohilmo

120

309

4.00

41.42

1.6

1.4

1841.42

4527.45

e6/l

0.47

220

627

3122

1.81

41.24

1.5

7459.70

2707.34

e6/l

1.50

444

2195

Substance abuse, excluding more controls

592

2705

1.84

41.02

1.5

8613.96

2518.28

e6/l

1.94

423

1879

Type 1 diabetes, wide definition, subgroup 1

213

782

2.76

40.80

1.6

1.5

1375.06

2654.76

e6/l

1.55

155

555

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

233

902

2.64

40.56

1.8

1.5

9891.96

3088.60

e6/l

0.69

157

635

Depression medications

104

5.53

40.45

1.6

1.3

3131.17

5648.83

e6/l

1.33

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

149

451

3.38

40.36

1.5

1402.02

2641.24

e6/l

1.09

320

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

223

380

2.96

40.22

1.4

1.3

1945.06

5307.23

e6/l

1.29

151

251

Fungal Sepsis

183

5.01

40.08

1.6

1.4

2000.39

6176.60

e6/l

0.44

133

Insulin, fast-acting or short human

428

2149

2.01

39.67

1.7

1.5

1531.58

2960.94

e6/l

1.83

306

1500

COPD, hospital admissions 1, only main diagnosis

514

2349

1.91

39.40

1.4

1.5

2665.27

2720.89

e6/l

0.03

373

1646

Malignant neoplasm, without specification of site, including Hilmo

201

4.73

39.38

1.3

1.4

1950.90

1389.32

e6/l

0.48

141

Gout, idiopatic and unspecified

397

1952

2.07

39.35

1.6

1.5

1621.93

2832.13

e6/l

1.36

259

1387

Cardiodefibrillation

504

2684

1.90

39.13

1.6

1.5

1590.79

3276.04

e6/l

2.09

348

1900

Alcohol use disorder, Swedish definition

597

3036

1.80

38.99

1.6

1.5

7736.26

2738.95

e6/l

1.51

423

2132

Coronary artery bypass grafting

395

1413

2.11

38.81

1.5

1158.30

3291.28

e6/l

2.40

278

1015

Infections of the skin and subcutaneous tissue

566

3084

1.82

38.69

1.6

1.5

4163.73

3560.36

e6/l

0.13

397

2155

Diseases of the digestive system

567

3135

1.81

38.22

1.6

1.4

4533.70

2800.96

e6/l

0.47

420

2208

Pure hypercholesterolaemia

767

2887

1.70

38.20

1.5

1.4

3759.24

2750.80

e6/l

0.36

528

2062

Parasetamol

580

1572

1.87

38.18

1.5

1.4

4059.67

2365.32

e6/l

0.55

402

1090

637

3173

1.76

38.12

1.5

7344.32

2858.41

e6/l

1.41

453

2232

Mental and behavioural disorders due to psychoactive substance use

610

3169

1.78

38.06

1.5

8359.51

2721.04

e6/l

1.82

438

2225

Other bacterial intestinal infections, including avohilmo

292

1293

2.29

37.66

1.6

1.5

2653.15

3015.07

e6/l

0.09

227

898

Other diseases of blood and blood-forming organs, wide

278

1210

2.33

37.40

1.5

5466.16

3025.93

e6/l

0.33

206

829

Vocal cord dysfunction

138

360

3.42

37.18

1.6

1.4

2353.63

3223.54

e6/l

0.71

106

251

Diarrhoea and gastroenteritis of presumed infectious origin

665

3469

1.72

37.15

1.5

1.4

2414.70

3594.67

e6/l

1.19

468

2405

Enlarged lymph nodes

188

682

2.80

37.04

1.6

1.4

2041.68

3821.33

e6/l

0.69

137

462

Substance abuse

592

3121

1.77

36.99

1.5

8613.96

2694.72

e6/l

1.86

423

2187

Implicit fungal Sepsis

166

5.02

36.56

1.5

1.4

1984.25

6720.38

e6/l

0.44

117

Antihypertensive medication - note that there are other indications

311

698

2.34

36.47

1.5

1.4

2535.06

4323.55

e6/l

1.52

201

490

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

614

3542

1.74

36.36

1.5

3727.21

2940.72

e6/l

0.19

445

2490

Disorders resulting from impaired renal tubular function

175

4.91

36.33

1.7

1.4

678.62

2037.05

e6/l

2.99

120

Gout, strict definition

306

1412

2.21

35.95

1.7

1.5

1591.80

2940.81

e6/l

1.07

199

1003

Type 1 diabetes, wide definition

221

881

2.53

35.93

1.6

1.5

1403.27

2530.61

e6/l

1.39

160

625

Malignant neoplasm of urinary organs

141

446

3.23

35.61

1.4

1.5

1380.47

2637.22

e6/l

1.10

319

Asthma and allergy, excluding more controls

10.17

35.42

1.7

1.2

2804.23

3943.42

e6/l

0.31

Cerebrovascular diseases

824

3544

1.62

35.19

1.5

2657.95

3315.72

e6/l

0.42

591

2489

Diabetes mellitus

869

3130

1.61

34.81

1.5

1.4

4101.81

3202.36

e6/l

0.30

578

2218

Diabetes, varying definitions

866

3130

1.61

34.80

1.5

1.4

4108.15

3202.35

e6/l

0.30

577

2216

Cough

361

1662

2.04

34.73

1.5

1.4

2329.14

3027.10

e6/l

0.50

274

1125

Malignant neoplasm of kidney, except renal pelvis

129

393

3.36

34.66

1.4

1.5

1482.99

2446.18

e6/l

0.77

280

Myocardial infarction, strict

533

2088

1.82

34.64

1.5

3182.25

3753.02

e6/l

0.13

377

1473

Ischaemic heart disease, wide definition

766

2874

1.65

34.21

1.5

4120.93

3519.25

e6/l

0.17

530

2021

Type 2 diabetes

857

3098

1.61

34.21

1.5

1.4

4118.10

3200.96

e6/l

0.31

573

2199

Use of hypnotics and sedatives

976

3603

1.56

33.67

1.5

3948.88

3161.68

e6/l

0.30

706

2525

Dipeptidyl peptidase 4 (DPP-4) inhibitors

663

3106

1.69

33.62

1.6

1.5

3158.09

3274.44

e6/l

0.03

474

2188

Cirrhosis of liver, NAS

108

302

3.71

33.34

1.8

1.4

1285.62

4421.63

e6/l

0.57

217

Fibrosis and cirrhosis of liver

135

435

3.19

33.21

1.7

1.4

1425.98

3734.57

e6/l

0.61

309

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

833

3092

1.61

33.18

1.5

1.4

2970.63

3196.51

e6/l

0.07

573

2197

GI-bleeding

442

2392

1.87

32.97

1.6

1.4

4700.87

2664.78

e6/l

0.44

334

1675

Osteopathies and chondropathies

572

3036

1.73

32.96

1.5

3221.99

3444.04

e6/l

0.11

403

2111

Other diseases of the digestive system

440

2379

1.87

32.94

1.6

1.4

4753.85

2658.96

e6/l

0.45

330

1665

Early onset COPD

268

1219

2.23

32.53

1.4

1.5

4958.35

2709.71

e6/l

0.62

190

834

Gout, unspecified

321

1573

2.08

32.26

1.7

1.5

1627.15

3076.72

e6/l

1.32

216

1115

Syncope and collapse

464

2120

1.84

32.23

1.6

1.4

5705.89

2877.65

e6/l

0.61

331

1490

Diseases of liver

380

1975

1.94

32.07

1.7

1.5

8300.88

2870.42

e6/l

0.95

257

1387

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

123

5.44

32.00

1.7

1.4

1836.31

1699.76

e6/l

0.09

Chronic lymphocytic leukaemia, helper endpoint

123

5.44

32.00

1.7

1.4

1836.31

1699.76

e6/l

0.09

Chronic lymphocytic leukaemia

123

5.44

32.00

1.7

1.4

1836.31

1699.76

e6/l

0.09

Acute peritonitis

113

335

3.48

31.85

1.7

1.4

1162.99

4279.63

e6/l

0.61

230

Benign neoplasm of colon, rectum, anus and anal canal

725

3812

1.62

31.79

1.5

1813.11

3391.01

e6/l

2.73

497

2716

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

155

370

2.99

31.39

1.5

1.4

5311.42

3403.53

e6/l

0.26

255

Iron deficiency anaemia secondary to blood loss (chronic)

223

958

2.37

31.08

1.5

1726.45

3353.76

e6/l

0.86

182

669

Fall on same level

964

3370

1.53

30.65

1.5

1.4

4947.82

3049.60

e6/l

0.69

654

2377

Endocrine, nutritional and metabolic diseases

569

1650

1.75

30.14

1.5

1.4

4307.19

3039.94

e6/l

0.35

384

1171

Other disorders of kidney and ureter

187

764

2.50

29.23

1.6

1.4

1229.54

3385.08

e6/l

1.08

118

532

1012

3429

1.50

29.16

1.5

1.4

2658.77

3352.93

e6/l

0.52

720

2409

All influenza (not pneumonia)

126

419

3.04

29.15

1.6

1.4

1749.34

4285.47

e6/l

0.66

307

Glomerulonephritis

135

469

2.94

29.07

1.5

1.4

1611.55

3688.93

e6/l

0.58

337

Hypertensive Renal Disease

209

4.08

28.96

1.7

1.4

542.96

1750.91

e6/l

5.49

166

Mental and behavioural disorders due to alcohol

513

2866

1.72

28.80

1.5

8547.09

2790.22

e6/l

1.52

366

2015

Disorders of lens

666

2547

1.63

28.61

1.5

3212.45

3616.68

e6/l

0.17

463

1796

Myocardial infarction, without ST-elevation

555

3007

1.68

28.48

1.4

1.5

3320.36

2762.37

e6/l

0.13

399

2139

Examination and observation for other reasons

544

1785

1.73

28.47

1.6

1.4

4317.28

3027.31

e6/l

0.31

393

1190

Viral hepatitis, IBD co-morbidity

110

5.27

28.15

1.5

1.4

28862.49

2392.39

e6/l

0.73

Abnormalities of heart beat

314

1547

1.98

28.15

1.5

1.4

2558.91

2746.99

e6/l

0.09

230

1042

Mental and behavioural disorders due to alcohol, excluding acute intoxication

456

2588

1.76

28.14

1.5

9529.33

2961.72

e6/l

1.53

321

1821

Amiodarone users

168

666

2.59

28.13

1.5

1372.18

3208.65

e6/l

0.74

110

475

Invasive ventilation

113

362

3.20

28.10

1.5

1.4

2110.63

4117.63

e6/l

0.35

250

Other acute lower respiratory infections

547

3131

1.67

28.03

1.5

4244.93

3085.47

e6/l

0.41

392

2206

Stroke, including SAH

722

3300

1.58

27.96

1.5

1964.95

3365.66

e6/l

1.92

519

2320

Non-small cell lung cancer, squamous, helper endpoint

114

370

3.19

27.89

1.4

1.5

8860.25

1834.27

e6/l

0.48

264

Agranulocytosis

144

530

2.77

27.84

1.5

8272.62

3715.82

e6/l

0.32

110

363

Other/unspecified cytomegaloviral diseases

7.63

27.80

1.3

1.4

909.59

3224.26

e6/l

1.41

Diabetes, insulin treatment (Kela reimbursement)

904

3590

1.50

27.22

1.5

1.4

2809.54

3499.02

e6/l

0.28

622

2522

Non-Hodgkin lymphoma, all

201

4.01

27.09

1.7

1.4

2142.02

1340.12

e6/l

1.16

142

Abnormal findings on examination of blood, without diagnosis

553

3046

1.66

26.89

1.6

1.5

2019.23

3314.25

e6/l

1.48

381

2165

Disorders of gallbladder, biliary tract and pancreas

918

3844

1.49

26.81

1.5

3433.34

3081.86

e6/l

0.12

650

2703

Other retinal disorders

717

3507

1.56

26.76

1.5

2834.21

2669.83

e6/l

0.06

508

2477

Pain, not elsewhere classified

247

1175

2.12

26.73

1.5

1.4

5057.72

3016.23

e6/l

0.84

162

812

Pneumonia due to Streptococcus pneumoniae

108

5.22

26.73

1.3

18359.34

1553.30

e6/l

0.51

Medicines for HER+ breast cancer

307

1467

1.97

26.65

1.4

3412.55

2896.07

e6/l

0.09

215

1021

Unspecified acute lower respiratory infection

184

778

2.40

26.62

1.4

1.5

5759.86

3519.78

e6/l

0.32

132

542

Codeine or tramadol medication

986

3642

1.48

26.57

1.5

4619.95

2931.05

e6/l

0.60

674

2580

Cytomegaloviral disease, including avohilmo

6.34

26.48

1.4

981.86

2442.02

e6/l

1.11

Disorders of choroid and retina

825

3831

1.52

26.44

1.5

3951.03

2964.21

e6/l

0.30

583

2711

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

7.80

26.13

1.7

1.4

774.54

1529.91

e6/l

1.04

Other CVD

298

1534

1.97

26.13

1.6

1.5

8585.89

2811.32

e6/l

0.78

219

1083

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

891

3793

1.49

25.99

1.6

1.4

3134.80

3286.30

e6/l

0.05

616

2689

Persons encountering health services for specific procedures, not carried out

248

3.56

25.95

1.6

1.4

19292.07

2540.94

e6/l

0.54

171

Diabetic retinopathy, excluding more controls

279

751

2.10

25.94

1.5

1.4

4340.83

3197.21

e6/l

0.13

199

497

Heart failure and hypertrophic cardiomyopathy

105

5.39

25.83

1.8

1.4

726.34

1789.10

e6/l

2.27

Cardiomyopathy, Hypertrophic obstructive

7.84

25.67

1.6

1.3

673.80

22235.43

e6/l

0.53

Cardiac arrest

179

3.86

25.55

1.5

1.3

2051.86

3125.82

e6/l

0.47

130

Gastroduodenal ulcer

355

1941

1.85

25.55

1.5

5145.61

2696.97

e6/l

0.42

262

1360

Diabetes medication

881

3464

1.49

25.37

1.5

1.4

3528.64

3545.22

e6/l

0.00

597

2438

Malignant neoplasm of breast, HER-negative

142

519

2.65

25.37

1.4

2933.35

2744.78

e6/l

0.06

361

Cytomegalovirus infection, IBD co-morbidity

6.20

25.33

1.4

1.3

981.86

2763.78

e6/l

1.37

Cytomegaloviral disease

6.19

25.32

1.4

981.86

2442.02

e6/l

1.11

Pneumonia derived septicemia

155

4.35

25.11

1.4

1466.19

1679.85

e6/l

0.20

106

Viral pneumonia (known virus, not influenza)

139

4.58

25.03

1.4

4170.67

1824.29

e6/l

0.47

Malignant neoplasm of breast, ER-negative, including Hilmo

149

546

2.57

24.97

1.4

2763.13

2683.13

e6/l

0.03

102

378

Convulsions, not elsewhere classified

209

949

2.19

24.67

1.5

1.4

11238.28

3473.10

e6/l

0.82

144

659

Intestinal infectious diseases, including avohilmo, including avohilmo

1022

3962

1.44

24.58

1.5

1.4

2625.83

3511.62

e6/l

0.75

727

2779

Hypokalaemia

151

606

2.53

24.55

1.4

7941.35

2571.22

e6/l

0.43

113

430

Symptoms and signs involving the digestive system and abdomen

870

2930

1.49

24.50

1.5

2777.39

3743.00

e6/l

0.79

608

2064

Factors influencing health status and contact with health services

248

577

2.17

24.43

1.4

1654.53

3440.80

e6/l

2.11

176

404

Cellulitis

241

1178

2.07

24.40

1.6

1.5

5804.66

3137.45

e6/l

0.30

172

814

Benign neoplasm: Colon

614

3692

1.57

24.31

1.5

1889.54

3378.26

e6/l

2.26

426

2618

Bronchitis

962

3995

1.45

24.18

1.5

2696.01

3305.91

e6/l

0.47

692

2804

L02BA Anti-estrogens

153

622

2.49

24.15

1.4

1388.86

2381.57

e6/l

1.81

103

425

Asthma/COPD (KELA code 203)

791

3536

1.50

24.13

1.5

4269.06

3136.86

e6/l

0.39

571

2466

Injuries to the head

958

3935

1.45

24.02

1.5

4722.42

3012.74

e6/l

0.68

673

2760

Pneumonia due to other infectious organisms, not elsewhere classified

5.37

24.02

1.5

1.3

2529.65

10242.39

e6/l

0.41

Used for control exclusion in common control thyroid runs

891

3053

1.48

23.80

1.6

1.4

3530.08

3425.06

e6/l

0.03

647

2127

Diffuse large B-cell lymphoma, helper endpoint

202

3.77

23.71

1.6

1.4

1872.09

1504.23

e6/l

0.42

145

Diffuse large B-cell lymphoma

202

3.77

23.71

1.6

1.4

1872.09

1504.23

e6/l

0.42

145

Diffuse large B-cell lymphoma, including Hilmo

202

3.77

23.71

1.6

1.4

1872.09

1504.23

e6/l

0.42

145

Sub-endpoint used in defining T1D endpoints

294

1530

1.91

23.61

1.5

1201.88

2854.60

e6/l

1.76

218

1065

Pneumococcal septicemia

154

4.24

23.59

1.3

1403.72

1649.19

e6/l

0.24

106

Other respiratory diseases principally affecting the interstitium

257

1306

2.00

23.49

1.5

3582.43

2968.59

e6/l

0.14

168

934

Substance use, excluding alcohol

167

716

2.35

23.41

1.4

1.5

15590.45

4046.10

e6/l

1.07

121

493

Other abnormalities of plasma proteins

6.02

23.19

2.0

1.3

1658.16

1765.60

e6/l

0.07

Stroke, excluding SAH

682

3238

1.53

23.02

1.5

1859.74

3183.00

e6/l

1.85

491

2269

Oesophageal varices

202

3.74

22.99

1.9

1.5

969.28

1768.56

e6/l

2.07

139

Clear cell adenocarcinoma of kidney

188

3.83

22.97

1.4

1250.24

1598.46

e6/l

0.56

134

Fentanyl

144

583

2.51

22.93

1.6

1.5

6867.46

2210.20

e6/l

0.44

119

429

Nausea and vomiting

279

1433

1.91

22.69

1.6

1.4

3592.97

3273.86

e6/l

0.07

195

990

Symptoms and signs involving the urinary system

739

3745

1.50

22.64

1.5

1.4

3990.13

3042.93

e6/l

0.39

528

2641

Chronic pancreatitis

160

686

2.37

22.58

1.6

1.4

10218.25

3289.06

e6/l

0.56

111

481

Intestinal stricture

368

2118

1.76

22.56

1.4

1.5

2636.33

2958.83

e6/l

0.15

260

1486

Alcoholic liver disease

139

560

2.53

22.53

1.8

1.4

15402.89

3839.78

e6/l

0.73

392

Malignant neoplasm, without specification of site

155

4.14

22.52

1.4

1.5

2209.51

1180.20

e6/l

0.72

107

L02BG Aromatase inhibitors

261

1333

1.95

22.48

1.4

3751.87

2909.01

e6/l

0.13

180

926

Other cataract

478

2167

1.65

22.41

1.5

2569.84

3287.66

e6/l

0.37

341

1526

Asthma (diagnoses ohter than nonallergic)

763

4198

1.47

22.04

1.5

3143.81

3255.85

e6/l

0.06

532

2961

Misadventures to patients during surgical and medical care

167

738

2.29

21.94

1.6

1.4

3617.89

3315.38

e6/l

0.06

128

519

Colorectal cancer, including Hilmo

255

1227

1.95

21.89

1.4

1.5

1090.89

3172.57

e6/l

1.82

182

878

Diseases of peritoneum

134

539

2.53

21.79

1.6

1.5

1195.63

3562.45

e6/l

0.83

383

Idiopathic gout

152

649

2.39

21.77

1.7

1.5

2617.92

3668.80

e6/l

0.27

452

Alcohol use disorder, ICD-based

405

2416

1.69

21.74

1.5

9882.66

2895.48

e6/l

1.41

285

1703

Autoimmune diseases

930

3296

1.44

21.67

1.6

1.4

3492.24

3327.69

e6/l

0.05

681

2291

Osteomyelitis

343

2.96

21.61

1.7

1.4

3828.64

4353.04

e6/l

0.06

237

Type 2 diabetes, strict (exclude DM1)

781

3095

1.47

21.34

1.5

1.4

4629.23

3189.91

e6/l

0.48

513

2197

Pain in limb

721

3082

1.49

21.32

1.5

1.4

2517.46

3168.75

e6/l

0.60

473

2164

Type 2 diabetes, definitions combined

775

3068

1.47

21.29

1.5

1.4

4570.07

3200.17

e6/l

0.44

509

2180

Asthma and allergy

5.58

21.20

1.7

1.2

2804.23

2495.61

e6/l

0.08

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

204

3.57

21.12

1.7

1.5

930.44

1508.28

e6/l

1.12

144

Injuries to the thorax

489

3079

1.60

21.09

1.5

3894.63

3438.48

e6/l

0.16

353

2159

Mental and behavioural disorders due to use of other stimulants, including caffeine

8.60

21.07

1.5

1.3

50902.07

2676.32

e6/l

0.48

Chronic viral hepatitis

103

4.74

21.05

1.6

1.3

33636.70

2040.26

e6/l

0.75

Paralytic ileus and intestinal obstruction

311

1743

1.80

20.88

1.5

2970.73

3009.10

e6/l

0.01

220

1239

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

116

4.45

20.80

1.4

10962.43

2488.21

e6/l

0.72

Diabetic maculopathy, excluding more controls

127

509

2.53

20.80

1.6

1.4

952.28

2067.24

e6/l

1.87

100

373

Other soft tissue disorders, not elsewhere classified

797

3114

1.46

20.77

1.5

1.4

2778.31

3161.78

e6/l

0.29

524

2190

Fracture of femur

370

1960

1.72

20.77

1.4

1.5

4017.71

3117.83

e6/l

0.14

267

1376

Small cell lung cancer

117

4.52

20.75

1.3

1.4

3545.11

1277.98

e6/l

1.36

Small cell lung cancer, including Hilmo

117

4.52

20.75

1.3

1.4

3545.11

1277.98

e6/l

1.36

Malignant neoplasm of other and ill-defined sites, including Hilmo

6.59

20.74

1.5

1.3

1503.60

1851.03

e6/l

0.21

Insulin, fast-acting (human)

127

510

2.52

20.65

1.5

1.4

885.32

3971.84

e6/l

1.13

358

Amputation of foot

173

3.82

20.24

1.6

1.5

2679.85

1665.99

e6/l

0.21

128

Volume depletion

138

583

2.41

20.21

1.5

1178.64

2164.81

e6/l

1.54

104

421

Fracture of rib(s), sternum and thoracic spine

355

2089

1.72

20.16

1.5

3974.34

2850.67

e6/l

0.41

256

1474

Ischaemic Stroke, excluding all haemorrhages

645

3182

1.50

20.09

1.5

1813.55

3140.01

e6/l

1.81

462

2228

Malignant neoplasm of head and neck, including Hilmo

110

419

2.67

19.99

1.4

1.5

3426.69

2080.51

e6/l

0.50

296

Chronic ulcer of skin, not elsewhere classified

108

409

2.70

19.97

1.6

1.4

2996.32

3867.15

e6/l

0.14

286

Other symptoms and signs involving the circulatory and respiratory systems

231

3.30

19.94

1.6

1.3

3543.62

1810.22

e6/l

0.95

157

Nephrotic syndrome

125

4.30

19.93

1.6

1.4

1647.74

2283.46

e6/l

0.34

Senile cataract

614

2463

1.52

19.88

1.5

2402.74

3422.10

e6/l

0.75

427

1735

Other or ill-defined heart diseases

121

4.28

19.74

1.6

1.2

1594.15

10213.95

e6/l

0.62

Left ventricular outflow tract obstruction (LVOTO), broad definition

105

394

2.71

19.67

1.4

1.5

5974.26

4651.37

e6/l

0.12

281

Charcot foot

6.22

19.66

1.6

1.2

3586.85

1673.15

e6/l

0.33

Coagulation defects, purpura and other haemorrhagic conditions

205

1029

2.01

19.42

1.4

1.5

3325.33

3174.40

e6/l

0.03

158

719

Unspecified privation

124

508

2.48

19.42

1.7

1.4

3385.26

3515.79

e6/l

0.02

359

Malignant neoplasm of head and neck

352

2.80

19.40

1.4

2719.00

2250.21

e6/l

0.16

247

Secondary right heart disease

252

3.20

19.36

1.4

934.27

1497.13

e6/l

1.60

176

Open wound of lower leg

162

746

2.20

19.30

1.5

2418.37

3798.48

e6/l

0.53

116

526

Other viral hepatitis, including avohilmo

145

3.92

19.30

1.6

1.4

28289.19

2350.26

e6/l

0.73

Squamous cell neoplasms and carcinomas of the skin

133

564

2.40

19.29

1.4

1.5

1014.39

2178.71

e6/l

1.55

409

Other diseases of intestines

832

3254

1.43

19.26

1.5

1.4

2454.68

3812.31

e6/l

1.43

565

2310

Need for other prophylactic measures

252

3.17

19.26

1.5

1.4

2588.74

1667.79

e6/l

0.73

174

Malignant neoplasm of oesophagus, including Hilmo

155

3.86

19.25

1.4

1973.86

1636.43

e6/l

0.23

111

Polyneuropathies and other disorders of the peripheral nervous system

265

1456

1.84

19.16

1.5

1581.52

3181.04

e6/l

1.52

189

1025

Other disorders of glucose regulation and pancreatic internal secretion

101

377

2.72

19.15

1.7

1.4

13459.61

3988.35

e6/l

0.46

268

Other viral hepatitis

137

4.00

19.14

1.6

1.4

29708.06

2409.68

e6/l

0.73

Disorders of thyroid, IBD co-morbidities

143

414

2.38

19.08

1.6

1.3

2021.32

3376.20

e6/l

0.38

284

Myelodysplastic syndrome, including Hilmo

148

3.92

18.92

1.4

1043.02

1447.35

e6/l

0.67

Unspecified haematuria

493

2588

1.56

18.77

1.5

2789.14

3067.41

e6/l

0.15

345

1842

Pleural plaque with presence of asbestos

137

599

2.35

18.76

1.4

1.5

1889.78

3764.28

e6/l

0.61

122

411

Myocarditis

101

4.52

18.70

1.4

1.2

2730.30

3764.30

e6/l

0.29

Sequelae of external causes of morbidity and mortality

273

1525

1.81

18.66

1.6

1.4

1964.70

2972.74

e6/l

0.80

183

1058

Colorectal cancer

226

1139

1.92

18.60

1.5

1050.32

2418.37

e6/l

3.07

165

812

Retention of urine

435

2209

1.61

18.57

1.6

1.5

4965.46

3123.88

e6/l

0.47

299

1593

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

156

712

2.20

18.53

1.4

1092.02

2383.30

e6/l

1.54

108

516

Medical observation and evaluation for suspected diseases and conditions

550

1824

1.55

18.51

1.5

1.4

2345.78

2966.58

e6/l

0.47

418

1223

Gastric ulcer

229

1216

1.91

18.46

1.5

2986.80

2560.50

e6/l

0.11

171

841

Exposure to unspecified factor

851

4140

1.40

18.43

1.5

1.4

3841.61

3249.98

e6/l

0.17

539

2966

Hernia

792

3716

1.42

18.41

1.4

1.5

2351.12

3535.94

e6/l

1.32

547

2616

Decubitus ulcer and pressure area

105

411

2.62

18.23

1.5

1.4

2228.64

3888.96

e6/l

0.32

297

Symptoms and signs concerning food and fluid intake

124

524

2.39

18.07

1.5

1.4

1967.80

4009.37

e6/l

0.60

362

Hyperlipidaemia, other/unspecified

422

2389

1.60

18.07

1.5

1731.88

2642.77

e6/l

1.53

272

1704

Other disorders of skin and subcutaneous tissue, not elsewhere classified

165

787

2.12

18.04

1.5

4620.24

3329.94

e6/l

0.23

128

562

Bronchiectasis

108

431

2.56

17.98

1.5

1.4

2470.71

4143.55

e6/l

0.35

292

Non-follicular lymphoma

135

596

2.31

17.97

1.6

1.5

1956.07

3516.49

e6/l

0.51

417

Type 2 diabetes, definitions combined, including avohilmo

755

3057

1.43

17.92

1.5

1.4

4641.82

3216.20

e6/l

0.45

496

2163

Hypotension

247

1360

1.84

17.81

1.6

1.5

10166.72

2782.42

e6/l

0.84

179

960

Drug-induced neutropenia

341

2.75

17.77

1.5

1.4

2296.78

4856.68

e6/l

0.46

233

Persons encountering health services in other circumstances, wide

981

3688

1.37

17.68

1.5

1.4

3821.07

3244.62

e6/l

0.20

630

2674

Hypertrophic cardiomyopathy

224

3.22

17.67

1.7

1.4

714.58

5507.69

e6/l

0.66

156

Emphysema

110

448

2.51

17.56

1.3

1.5

3746.18

3575.37

e6/l

0.03

306

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

139

605

2.25

17.54

1.7

1.5

1832.51

4154.48

e6/l

0.85

102

419

Hepatic failure, not elsewhere classified

185

3.45

17.51

1.8

1.3

1402.07

1777.02

e6/l

0.33

127

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

497

2.41

17.46

1.6

1.4

3598.09

3714.92

e6/l

0.02

343

Injuries to the abdomen, lower back, lumbar spine and pelvis

403

2505

1.60

17.40

1.6

1.5

5802.07

2852.61

e6/l

0.59

287

1754

Symptoms and signs involving cognition, perception, emotional state and behaviour

815

3906

1.40

17.37

1.5

5263.11

2845.50

e6/l

0.80

575

2739

Secondary malignant neoplasm of respiratory and digestive organs

5.09

17.28

1.3

1.4

783.69

1592.46

e6/l

1.16

Malignant neoplasm of oral cavity, including Hilmo

162

3.60

17.27

1.4

2640.05

1498.25

e6/l

0.28

113

Purpura and other haemorrhagic conditions

153

722

2.15

17.22

1.5

2219.72

3676.38

e6/l

0.48

118

507

Haemorrhage, not elsewhere classified

212

3.25

17.22

1.3

939.79

5792.34

e6/l

0.63

149

Hodgkin lymphoma, hilmo

105

4.32

17.05

1.8

1.3

1401.48

1800.09

e6/l

0.44

Other and unspecified polyneuropathies, also in other diseases

235

1293

1.84

17.00

1.6

1.5

1525.94

3112.77

e6/l

1.31

167

912

Other pulmonary heart/vessel disease

283

2.91

16.97

1.4

1016.82

4678.51

e6/l

0.63

198

Immunodeficiencies

165

3.53

16.81

1.6

1.3

1745.15

1681.13

e6/l

0.05

101

Osteoporosis

289

1550

1.73

16.78

1.5

1.4

3506.55

2824.39

e6/l

0.26

207

1078

Mycoses

268

1539

1.76

16.71

1.5

3122.27

3000.48

e6/l

0.03

189

1062

Aortic valve malfunction, age under 60 years

369

2.61

16.70

1.4

1.5

6269.71

4883.45

e6/l

0.11

263

Mental and behavioural disorders due to opioids

5.62

16.52

1.8

1.2

3164.67

2474.72

e6/l

0.23

Diseases of the skin and subcutaneous tissue

799

2865

1.40

16.51

1.5

1.4

2609.85

2996.90

e6/l

0.30

552

2039

Lymphoid leukaemia

315

2.77

16.50

1.7

1.4

5368.82

4419.02

e6/l

0.10

216

Other (not insulin) diabetes medications

807

3410

1.39

16.48

1.5

1.4

3814.74

3543.81

e6/l

0.08

545

2403

Cutaneous abscess, furuncle and carbuncle

226

1239

1.84

16.46

1.7

1.5

2904.69

3096.55

e6/l

0.05

161

862

Malignant neoplasm of colon, including Hilmo

179

908

1.98

16.33

1.4

1.5

1123.05

2525.81

e6/l

2.32

135

648

Certain disorders involving the immune mechanism

178

907

1.98

16.26

1.7

1.4

1899.13

3536.55

e6/l

0.92

126

631

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

143

651

2.15

16.25

1.7

1.5

1819.07

4005.21

e6/l

0.87

105

453

Immunodeficiency with predominantly antibody defects

5.00

16.24

1.6

1.3

1888.28

2058.37

e6/l

0.09

L04AX Other immunosuppressants

447

2931

1.53

16.23

1.5

2950.79

3521.90

e6/l

0.37

306

2045

111

470

2.38

16.18

1.5

1.4

5756.93

3931.57

e6/l

0.16

338

Injuries to the hip and thigh

519

3145

1.49

16.12

1.5

3319.13

2801.64

e6/l

0.11

366

2216

Intracranial trauma

452

1984

1.54

16.08

1.5

1.4

3440.62

2952.00

e6/l

0.19

320

1344

Status post-ami

315

1438

1.68

15.88

1.5

2322.93

2523.47

e6/l

0.07

234

1031

Malignant neoplasm of other and ill-defined digestive organs

7.65

15.86

1.3

1.5

3610.38

2105.41

e6/l

0.25

Falls/tendency to fall

809

2925

1.39

15.79

1.5

1.4

1725.98

3160.35

e6/l

3.09

550

2074

Elevated blood glucose level

392

2.51

15.75

1.6

1.4

1295.66

4007.04

e6/l

0.68

284

Diabetic retinopathy

380

1477

1.61

15.75

1.5

3731.74

3325.95

e6/l

0.06

271

1022

Systemic lupus erythematosus, unspecified

4.85

15.72

1.6

1.3

4262.65

1881.22

e6/l

0.91

Systemic lupus erythematosus

103

4.17

15.68

1.5

1.3

4112.03

2025.75

e6/l

0.87

Second line medication for Crohn's disease

451

2985

1.52

15.65

1.5

1.4

2949.77

3707.97

e6/l

0.52

308

2087

Benzodiazepine use

841

4167

1.37

15.65

1.4

1.5

4508.80

3077.73

e6/l

0.55

589

2940

Artificial opening status

274

2.84

15.54

1.6

1.3

6392.31

4976.84

e6/l

0.12

186

Angina pectoris

517

2312

1.49

15.51

1.5

3887.03

3620.39

e6/l

0.05

353

1629

Congenital malformations of heart and great arteries

107

440

2.38

15.51

1.7

1.5

2354.99

4006.24

e6/l

0.38

310

Viral pneumonia (unknown virus, not influenza)

263

2.86

15.49

1.7

1.4

1754.39

4955.68

e6/l

0.47

184

Malignant neoplasm of other connective and soft tissue, including Hilmo

150

3.54

15.45

1.4

960.69

1623.10

e6/l

1.58

101

Amyloidosis

118

3.96

15.45

1.6

1.4

666.26

1316.81

e6/l

1.73

Malignant melanoma

143

688

2.10

15.34

1.6

1.5

1843.09

2526.85

e6/l

0.65

100

485

Hypoglycaemia, other or unspecified

298

2.73

15.34

1.7

1.4

14785.86

1669.88

e6/l

0.55

209

Acute bronchitis

397

2524

1.55

15.26

1.5

3268.17

2798.76

e6/l

0.16

284

1781

Unstable angina pectoris

398

2015

1.56

15.23

1.5

4185.11

3381.35

e6/l

0.14

274

1431

Malignant melanoma, including Hilmo

156

778

2.02

15.18

1.6

1.5

1769.44

2357.21

e6/l

0.61

108

548

Other or unspecified ileus, impaction or obstruction

221

1236

1.81

15.17

1.5

1.4

1781.79

2924.68

e6/l

0.68

158

879

Malignant neoplasm of tongue, including Hilmo

4.40

15.11

1.5

1.3

3425.48

1831.72

e6/l

0.26

ILD medications: azathioprine

114

505

2.28

15.02

1.6

1.4

2749.96

4025.94

e6/l

0.31

353

SLE (Finngen)

107

4.01

14.92

1.5

1.3

4112.03

2176.10

e6/l

0.79

Diagnoses used for exclusion with ILD

274

1636

1.69

14.91

1.5

1861.73

2760.12

e6/l

0.80

192

1144

Constipation

795

3952

1.37

14.91

1.5

3397.90

3202.95

e6/l

0.09

567

2789

Open wound of head

522

3374

1.46

14.90

1.5

3684.75

2974.05

e6/l

0.22

366

2377

Left bundle-branch block

252

2.86

14.89

1.4

1.3

1196.86

6228.34

e6/l

0.81

174

Other gastritis (incl. Duodenitis)

238

1369

1.75

14.85

1.6

1.4

2222.68

3041.90

e6/l

0.42

157

948

SLE, ICD10

4.20

14.71

1.5

1.3

4231.00

2068.43

e6/l

0.88

SLE, strict definition

4.20

14.71

1.5

1.3

4231.00

2068.43

e6/l

0.88

Amyloidosis, other/unspecified

100

4.17

14.70

1.6

1.4

659.93

1437.10

e6/l

1.86

Diverticular disease of intestine

674

2998

1.41

14.67

1.5

1.4

2918.62

3538.20

e6/l

0.37

453

2149

Abnormal findings on diagnostic imaging of other body structures

135

649

2.10

14.54

1.8

1.4

2083.07

2035.02

e6/l

0.03

450

Other viral diseases

197

1075

1.84

14.43

1.4

1.5

2437.19

3384.56

e6/l

0.44

124

747

Viral hepatitis, including avohilmo

213

2.99

14.42

1.6

1.4

26157.10

2104.00

e6/l

0.74

145

Interstitial lung disease

200

1106

1.83

14.35

1.5

4330.42

2934.39

e6/l

0.28

127

785

Interstitial lung disease endpoints

200

1106

1.83

14.35

1.5

4330.42

2934.39

e6/l

0.28

127

785

Gastrointestinal diseases

374

1181

1.59

14.35

1.5

1.4

4711.15

3589.52

e6/l

0.19

263

831

Other interstitial pulmonary diseases

200

1108

1.83

14.27

1.5

4330.42

2930.55

e6/l

0.28

127

790

Sequelae with surgical and medical care as external cause

213

1201

1.79

14.27

1.6

1.4

1936.65

2950.03

e6/l

0.62

139

831

Viral hepatitis

204

3.03

14.24

1.6

1.4

27345.68

2087.54

e6/l

0.73

138

Congenital malformations of cardiac septa

177

3.16

14.19

2.0

1.4

2017.85

1805.12

e6/l

0.08

116

Other diseases of intestine

175

931

1.90

14.16

1.5

1863.62

3109.23

e6/l

0.64

114

652

ILD, hospital admissions

195

1079

1.83

13.98

1.5

4407.90

2978.64

e6/l

0.28

124

762

Infection of intervertebral disc (pyogenic)

4.93

13.94

1.8

1.4

6555.11

1470.07

e6/l

0.62

Hydronephrosis

123

581

2.14

13.92

1.4

936.82

3638.33

e6/l

1.14

419

Abdominal and pelvic pain

793

2930

1.36

13.85

1.5

2680.86

3743.00

e6/l

0.89

557

2064

Reimbursement for rheumatic diseases

459

3114

1.47

13.82

1.5

2836.86

3283.59

e6/l

0.29

316

2188

341

2172

1.56

13.74

1.4

2641.02

3126.64

e6/l

0.30

237

1531

Malignant neoplasm of oral cavity

123

3.66

13.74

1.5

797.39

1648.43

e6/l

2.04

Persons encountering health services for other counselling and medical advice, not elsewhere classified

908

3638

1.33

13.64

1.6

1.4

3649.31

3277.37

e6/l

0.11

577

2632

Vascular disorders of the intestines

101

446

2.31

13.56

1.4

1.5

1523.63

3561.92

e6/l

0.52

317

Chronic nephritic syndrome

169

3.21

13.51

1.6

1.4

1799.62

1706.71

e6/l

0.04

115

Fracture of lumbar spine and pelvis

258

1557

1.67

13.42

1.6

1.5

6851.30

3167.30

e6/l

0.47

186

1095

Azathioprine

114

530

2.17

13.41

1.6

1.4

2749.96

3985.96

e6/l

0.31

367

Rare circulating lymphoid malignancy, including Hilmo

102

3.92

13.40

1.7

1.4

8877.75

2197.52

e6/l

0.88

Other and unspecified local infections of skin and subcutaneous tissue

101

448

2.28

13.37

1.6

1.4

2495.83

4094.56

e6/l

0.37

319

Tobacco use

186

3.06

13.28

1.5

1.4

2002.45

6685.72

e6/l

0.46

123

Other external causes of accidental injury

623

2225

1.41

13.20

1.5

1.4

1873.83

3138.81

e6/l

1.88

435

1584

Late syphilis

5.42

13.09

1.6

1.4

4996.00

1951.77

e6/l

0.32

Vitreous haemorrhage

116

551

2.13

13.00

1.4

1.5

1833.05

3943.61

e6/l

0.60

389

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

4.59

12.96

1.3

2668.67

1738.87

e6/l

0.21

Asthma and opportunity respiratory infection

267

2.69

12.95

1.4

2465.57

4805.45

e6/l

0.32

189

Malignant neoplasm of stomach, including Hilmo

255

2.71

12.93

1.3

1.5

1499.04

1286.96

e6/l

0.20

180

Systemic sclerosis

4.55

12.92

1.7

1.3

2281.89

1830.56

e6/l

0.20

Lung diseases due to external agents

176

968

1.84

12.90

1.4

1.5

1477.64

2947.17

e6/l

0.88

126

683

Thyrotoxicosis

203

1163

1.76

12.89

1.5

1648.99

3660.33

e6/l

1.31

137

808

Atrial septal defect

3.94

12.88

2.1

1.3

1430.68

1905.49

e6/l

0.38

Injury of other and unspecified intrathoracic organs

326

2.50

12.87

1.4

1.5

2117.41

4251.16

e6/l

0.38

232

Malignant neoplasm of stomach

228

2.81

12.83

1.3

1.5

1547.61

1297.69

e6/l

0.22

163

Other viral diseases, including avohilmo

230

1351

1.69

12.81

1.4

1.5

2400.13

3215.74

e6/l

0.47

142

947

Superficial injury of head

229

1358

1.70

12.79

1.5

6933.30

3603.59

e6/l

0.37

165

941

Attention to artificial openings

180

3.06

12.78

1.2

1.3

4313.39

2082.64

e6/l

0.55

124

Abnormal results of function studies

333

2.46

12.74

1.6

1.4

1780.72

1697.70

e6/l

0.08

228

Thyrotoxicosis, other and/or unspecified

162

872

1.87

12.66

1.5

1729.25

3906.71

e6/l

0.98

109

596

Acute pancreatitis

200

1150

1.75

12.59

1.5

6782.57

2974.34

e6/l

0.37

144

805

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

107

3.74

12.55

1.7

1.3

1909.00

2624.63

e6/l

0.37

Diabetic retinopathy, strict definition

183

907

1.81

12.53

1.6

1.5

1304.67

3687.56

e6/l

1.26

133

609

Congenital malformations of the circulatory system

114

528

2.12

12.53

1.8

1.4

2205.28

3838.06

e6/l

0.46

370

Problems related to lifestyle

379

2.34

12.48

1.6

1.4

2901.05

4631.32

e6/l

0.33

273

Other diseases of arteries and capillaries

449

2.23

12.47

1.5

1.4

954.31

4855.55

e6/l

1.30

323

Seropositive rheumatoid arthritis

242

1460

1.66

12.47

1.5

1.4

3449.00

3266.00

e6/l

0.06

176

1018

Vascular diseases of the intestine

228

2.79

12.32

1.3

1.4

1840.25

1684.82

e6/l

0.08

163

In situ neoplasms

388

2628

1.49

12.30

1.5

2816.47

2780.32

e6/l

0.01

246

1865

Other infectious diseases, including avohilmo

106

498

2.16

12.25

1.6

1.4

3430.82

3493.64

e6/l

0.01

351

Biguanides

780

3547

1.33

12.18

1.5

1.4

3869.64

3465.19

e6/l

0.12

528

2503

Multiple myeloma, including Hilmo

196

2.92

12.18

1.4

1.5

944.92

1500.21

e6/l

1.20

137

Systemic connective tissue disorders

311

2016

1.55

12.15

1.5

3199.91

2850.86

e6/l

0.13

208

1416

Dysphagia

253

1565

1.63

12.10

1.4

1.5

1585.71

2908.61

e6/l

1.08

174

1084

Dermatitis

528

3707

1.40

12.09

1.5

1.4

4071.48

3120.09

e6/l

0.33

378

2595

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

102

475

2.18

12.09

1.8

1.4

2921.17

3642.40

e6/l

0.12

341

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

4.31

12.08

1.5

1.3

4101.45

1984.62

e6/l

0.28

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

373

2.34

12.07

1.5

1.4

5326.72

4027.85

e6/l

0.15

261

Systemic sclerosis, icd10

4.40

12.01

1.7

1.3

2409.65

1693.34

e6/l

0.32

Rheumatoid arthritis

309

1770

1.55

11.97

1.5

1.4

3398.28

3352.51

e6/l

0.02

222

1249

Fracture of lower leg, including ankle

445

3051

1.44

11.93

1.5

1.4

4214.15

3609.29

e6/l

0.14

294

2138

Other local infections of skin and subcutaneous tissue

104

490

2.15

11.92

1.6

1.4

2435.68

3934.50

e6/l

0.38

350

Intracranial and intraspinal abscess and granuloma

6.07

11.90

1.3

1.5

1994.60

2159.58

e6/l

0.08

Malignant neoplasm of oesophagus

116

3.54

11.90

1.4

1141.42

1730.34

e6/l

0.77

Seropositive rheumatoid arthritis, wide

242

1487

1.64

11.90

1.5

1.4

3449.00

3190.06

e6/l

0.09

176

1029

Accidents

613

2225

1.38

11.89

1.5

1.4

1883.32

3138.81

e6/l

1.85

434

1584

Use of anticholinesterases

211

2680

0.60

11.88

1.3

1.5

2655.51

2562.95

e6/l

0.03

161

1880

N06DA Anticholinesterases

211

2680

0.60

11.88

1.3

1.5

2655.51

2562.95

e6/l

0.03

161

1880

Other viral diseases, not elsewhere classified

139

725

1.92

11.86

1.5

2981.00

3340.03

e6/l

0.09

512

Other embolism and thrombosis

137

715

1.94

11.85

1.5

8109.60

3527.06

e6/l

0.31

102

517

Other other unspecified disorders of the circulatory system

183

2.97

11.85

1.8

1.4

1452.62

1695.25

e6/l

0.26

125

Other disorders involving the immune mechanism, not elsewhere classified

112

3.56

11.75

1.7

1.3

1909.00

2571.48

e6/l

0.34

Chronic gastritis

285

1827

1.57

11.75

1.5

1.4

6936.24

2698.21

e6/l

0.62

199

1279

Malignant neoplasm of colon

144

766

1.90

11.73

1.4

1.5

1140.34

2657.86

e6/l

1.98

111

538

Benign neoplasms

755

3090

1.33

11.71

1.5

1.4

2221.94

4069.46

e6/l

2.32

535

2179

Disorders of mineral metabolism

397

2.27

11.70

1.5

1.4

1729.44

2829.93

e6/l

0.78

279

Colorectal adenocarcinoma

182

1027

1.76

11.68

1.4

1.5

1100.72

2381.05

e6/l

2.41

130

735

Other special examinations and investigations of persons without complaint or reported diagnosis

511

1824

1.42

11.67

1.6

1.4

2309.19

2966.58

e6/l

0.48

372

1223

Other arthritis (FG)

267

1692

1.59

11.55

1.5

1.4

3197.39

3942.08

e6/l

0.27

184

1182

Malignant melanoma of skin, including Hilmo

123

624

1.99

11.54

1.6

1.5

1618.94

2532.98

e6/l

0.91

443

Rheumatoid arthritis, including avohilmo

329

2185

1.51

11.52

1.5

1.4

3416.99

2839.40

e6/l

0.30

238

1526

Acidosis

3.80

11.50

1.5

17788.04

1366.08

e6/l

0.57

Duodenal ulcer

140

745

1.90

11.46

1.5

1.4

8134.42

3051.81

e6/l

0.36

104

529

Unspecified fall

457

3175

1.42

11.42

1.5

1.4

5376.41

2923.57

e6/l

0.48

311

2228

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

806

3956

1.31

11.39

1.5

1.4

2504.49

3504.25

e6/l

1.12

565

2768

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

232

1429

1.64

11.32

1.5

3538.41

3148.70

e6/l

0.14

169

992

Malignant melanoma of skin

104

500

2.10

11.32

1.6

1.5

1722.19

2824.49

e6/l

0.91

357

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

390

2.26

11.31

1.5

1.4

1075.06

4039.51

e6/l

0.73

272

Cardiomyopathy in other diseases

10.94

11.29

1.6

1.3

712.20

836.83

e6/l

0.12

Cholecystitis

160

892

1.81

11.27

1.4

1.5

7088.31

3051.89

e6/l

0.32

121

628

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

255

1609

1.59

11.24

1.4

1.5

1799.52

3376.24

e6/l

1.40

172

1114

Sulfasalazine

215

1301

1.66

11.23

1.5

1.4

3033.72

3610.74

e6/l

0.23

146

874

Conotruncal defects

13.11

11.22

1.6

4770.17

3013.56

e6/l

—

Malnutrition

3.81

11.21

1.4

1.2

4660.08

2278.44

e6/l

0.26

ILD, hospital admissions 1, main diag only

169

963

1.78

11.10

1.5

4937.59

2854.41

e6/l

0.37

105

681

Late syphilis, including avohilmo

4.50

11.08

1.6

1.4

4715.12

2080.30

e6/l

0.29

Other infectious diseases

421

2.19

11.00

1.6

1.4

3868.61

3826.10

e6/l

0.01

293

Adenocarcinoma and ductal carcinoma of pancreas

153

3.07

10.98

1.4

6388.49

1531.34

e6/l

0.64

108

Candidiasis, including avohilmo

224

1378

1.63

10.97

1.6

1.4

4591.93

3389.29

e6/l

0.24

164

957

Primary biliary cholangitis, wide definition

4.19

10.94

1.5

1.3

1550.37

2048.76

e6/l

0.37

Small cell lung cancer, helper endpoint

181

2.90

10.92

1.3

1.4

3545.11

1685.56

e6/l

1.03

121

Other/unspecified seropositive rheumatoid arthritis

235

1467

1.61

10.88

1.5

3507.33

3208.33

e6/l

0.10

171

1018

Septal defects

166

2.93

10.82

1.9

1.4

1598.24

2020.16

e6/l

0.30

110

Other disorders of white blood cells

268

2.51

10.78

1.5

1.4

3010.94

5218.58

e6/l

0.28

182

Morphin

114

3.43

10.77

1.7

1.5

1207.06

1086.87

e6/l

0.16

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

227

2.64

10.75

1.7

1.5

1194.09

1364.15

e6/l

0.14

162

Candidiasis

123

641

1.94

10.71

1.6

1.4

4667.56

3417.26

e6/l

0.16

443

Arthropathies in other diseases classified elsewhere

161

2.98

10.67

1.5

1.3

3666.39

1556.40

e6/l

0.55

115

General examination and investigation of persons without complaint and reported diagnosis

490

1812

1.41

10.65

1.5

1.4

3484.36

2984.91

e6/l

0.20

394

1213

Genitourinary diseases

420

1457

1.45

10.64

1.5

1.4

1925.72

5118.63

e6/l

2.32

280

1027

Dizziness and giddiness

634

3704

1.33

10.61

1.4

1.5

3329.77

2725.62

e6/l

0.18

459

2614

Cholelithiasis, broad definition with cholecystitis

730

3711

1.31

10.60

1.5

3126.20

2924.19

e6/l

0.05

524

2616

Poisoning by drugs, medicaments and biological substances

146

808

1.82

10.51

1.4

7866.62

3390.84

e6/l

0.60

105

565

Acute pancreatitis (for exclusion)

200

1215

1.66

10.38

1.5

6782.57

2944.31

e6/l

0.38

144

850

Neuroendocrine tumor and carcinoma of small intestine

4.86

10.33

1.4

1.3

9939.33

1992.06

e6/l

0.40

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

152

845

1.78

10.30

1.4

1.5

7929.53

3633.89

e6/l

0.62

113

579

Malignant neoplasm of bladder, including Hilmo

128

677

1.89

10.26

1.3

1.5

1199.97

2608.14

e6/l

1.57

494

Malignant neoplasm of pancreas

311

2.35

10.26

1.4

1.5

4940.59

1365.63

e6/l

0.79

224

Primary biliary cholangitis (PBC)

4.19

10.21

1.5

1.2

1755.21

2011.51

e6/l

0.15

Other and unspecified types of non-Hodgkin lymphoma, hilmo

240

2.56

10.17

1.5

1.4

1783.71

1647.13

e6/l

0.13

168

Other viral diseases, not elsewhere classified, including avohilmo

168

972

1.73

10.16

1.4

1.5

2749.42

3298.80

e6/l

0.20

100

685

Myelodysplastic syndrome

4.48

10.16

1.4

918.47

1742.10

e6/l

0.80

Chronic periodontitis, complicated

486

3469

1.37

9.97

1.4

1.5

3322.33

3439.00

e6/l

0.06

304

2478

Benign neoplasm: Colon, unspecified

270

1779

1.53

9.94

1.5

1334.32

2870.91

e6/l

2.12

185

1244

Explicit fungal Sepsis

10.14

9.94

1.8

1.4

1064.46

1768.00

e6/l

0.39

Malignant neoplasm of other connective and soft tissue

100

3.49

9.94

1.2

1.3

919.30

1791.00

e6/l

1.54

Explicit fungal Sepsis, including avohilmo

10.13

9.94

1.8

1.4

1064.46

1768.00

e6/l

0.39

Viral infections characterized by skin and mucous membrane lesions

328

2246

1.47

9.88

1.5

4724.89

3409.95

e6/l

0.38

230

1564

Concussion

367

1977

1.44

9.88

1.5

1.4

3850.11

2958.43

e6/l

0.32

270

1339

Malignant neoplasm of cervix uteri, including Hilmo

5.21

9.86

1.4

1.1

624.87

1060.96

e6/l

0.60

Malignant neoplasm of pancreas, including Hilmo

387

2.17

9.86

1.4

1.5

4599.85

1898.79

e6/l

0.61

279

Other specified/unspecified systemic involvement of connective tissue

208

2.63

9.84

1.3

4127.33

2414.24

e6/l

0.45

134

Childhood asthma (age<16)

5.59

9.80

1.4

1.2

3378.08

2489.53

e6/l

0.29

Autoimmune diseases related-to ILD

650

4148

1.31

9.76

1.5

4872.56

3067.63

e6/l

0.55

460

2930

Benign neoplasm: Transverse colon

124

671

1.87

9.72

1.4

1.5

2767.31

3637.73

e6/l

0.23

477

Pneumocystosis, including avohilmo

3.52

9.71

1.6

1.3

2536.23

1581.19

e6/l

0.59

Pneumocystosis

3.52

9.71

1.6

1.3

2536.23

1581.19

e6/l

0.59

Syphilis, including avohilmo

3.48

9.66

1.5

1.4

4254.91

2091.90

e6/l

0.31

Syphilis

3.48

9.66

1.5

1.4

4254.91

2091.90

e6/l

0.31

Alcohol dependence

236

1519

1.56

9.65

1.6

1.5

8832.05

3008.43

e6/l

0.76

168

1052

Discitis, unspecified

3.74

9.64

1.5

1.3

41754.95

1415.68

e6/l

0.57

Exclusions for E4_PCOS_CONSORTIUM

411

1816

1.42

9.63

1.4

2292.21

3952.31

e6/l

1.39

285

1257

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

3.96

9.60

1.4

914.91

2263.61

e6/l

1.67

Thrombocytopenia, unspecified

372

2.18

9.60

1.5

1.4

1177.67

4014.91

e6/l

0.61

250

Atrial septal defect, secundum type

4.06

9.49

1.8

1.4

1585.65

2516.30

e6/l

0.45

Osteonecrosis

310

2.29

9.47

1.3

1.4

5289.61

4541.91

e6/l

0.08

215

External causes of morbidity and mortality

464

1675

1.39

9.45

1.5

1.4

3913.22

2453.79

e6/l

0.36

328

1177

Malignant neoplasm of endocrine gland, including Hilmo

218

2.55

9.44

1.4

1.5

2591.51

2316.63

e6/l

0.08

157

Aortic aneurysm

270

1765

1.51

9.40

1.4

1.5

2408.73

2967.63

e6/l

0.31

179

1275

Malignant neoplasm of tongue

4.04

9.38

1.6

1.3

977.31

1825.17

e6/l

1.03

Obesity related asthma

268

1785

1.51

9.36

1.6

1.5

2066.71

3432.81

e6/l

1.20

186

1249

Dentofacial anomalies [including malocclusion]

200

2463

0.63

9.31

1.5

1.4

3817.95

3768.98

e6/l

0.02

135

1695

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

300

2.30

9.27

1.6

1.5

1074.10

2080.12

e6/l

0.64

213

Disorders of calcium metabolism

307

2.28

9.23

1.5

1.4

1730.24

2374.91

e6/l

0.49

212

Other specified/unspecified arthritis

235

1528

1.55

9.20

1.5

1.4

3446.44

4102.19

e6/l

0.21

158

1083

Thyrotoxicosis with toxic multinodular goitre

308

2.28

9.18

1.8

1.4

1525.05

1713.12

e6/l

0.25

210

Fitting and adjustment of other devices

313

1895

1.46

9.17

1.4

3969.15

2632.63

e6/l

0.25

267

1348

Other diseases of pancreas

467

2.02

9.13

1.5

1.4

2133.98

3619.63

e6/l

0.35

327

DVT of lower extremities

191

1189

1.62

9.06

1.4

1.5

2100.01

3567.25

e6/l

0.72

133

843

Other complications of surgical and medical care, not elsewhere classified

414

2.07

9.04

1.5

1.4

1577.95

4568.69

e6/l

0.77

289

Weight loss

107

566

1.91

9.02

1.5

1.4

2855.86

3372.74

e6/l

0.11

392

Other and unspecified drugs and medicaments

388

2.11

9.02

1.5

1.4

999.02

4063.57

e6/l

0.76

273

Shock, not elsewhere classified

4.51

8.98

1.5

1.3

1116.75

1759.05

e6/l

0.57

Persons encountering health services for examination and investigation

495

1824

1.36

8.98

1.5

1.4

2585.37

2966.58

e6/l

0.24

368

1223

Adult respiratory distress syndrome

4.06

8.98

1.4

1.3

996.05

2069.78

e6/l

1.67

Use of other anti-dementia drugs

175

2257

0.62

8.96

1.4

1.5

3311.87

2649.66

e6/l

0.20

134

1582

Use of memantine

175

2257

0.62

8.96

1.4

1.5

3311.87

2649.66

e6/l

0.20

134

1582

Other and unspecified dermatitis

421

3072

1.38

8.94

1.5

1.4

4633.46

3254.87

e6/l

0.40

304

2130

Other antidepressants

834

3369

1.27

8.87

1.5

3978.16

2709.65

e6/l

0.50

585

2390

Drug-induced hypoglycaemia without coma

3.88

8.86

1.5

1.3

5313.67

2089.48

e6/l

0.39

Diabetic maculopathy

126

665

1.81

8.85

1.6

1.5

961.18

4413.96

e6/l

1.60

448

IgA nephropathy (IgA glomerulonephritis)

3.49

8.83

1.5

1.4

1564.83

2030.44

e6/l

0.24

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

214

2.51

8.82

1.8

1.4

1252.30

1325.22

e6/l

0.05

154

Systemic sclerosis (FG)

3.41

8.82

1.7

1.3

2281.89

2049.50

e6/l

0.09

Phlebitis and thrombophlebitis (not including DVT)

197

1245

1.59

8.78

1.5

2569.24

3801.89

e6/l

0.58

135

876

Sequelae of cerebrovascular disease

403

2496

1.39

8.77

1.4

1.5

1673.18

2805.15

e6/l

1.28

298

1769

Other/unspecified rheumatoid arthritis

122

679

1.82

8.77

1.5

1.4

3430.69

3435.41

e6/l

0.00

476

Asthma, hospital admissions , main diagnosis only

618

4152

1.30

8.69

1.5

1.4

3136.05

3423.72

e6/l

0.16

436

2910

Seropositive rheumatoid arthritis, strict definition

129

732

1.78

8.68

1.5

1.4

4082.64

3169.38

e6/l

0.22

498

Diaphragmatic hernia

335

2368

1.42

8.65

1.5

2453.02

3020.96

e6/l

0.34

222

1637

Diseases of spleen

3.70

8.63

1.5

1.4

1286.79

1795.02

e6/l

0.66

Use of rivastigmine

1372

0.47

8.62

1.3

1.4

1218.85

2637.89

e6/l

1.32

977

Complications of cardiac and vascular prosthetic devices, implants and grafts

126

3.03

8.60

1.6

1.4

2180.15

1433.41

e6/l

0.21

Failure and rejection of transplanted organs and tissues

6.58

8.56

1.3

1.4

9134.85

3572.42

e6/l

0.32

Malignant neoplasm of small intestine

3.49

8.55

1.4

1.3

8718.57

2030.05

e6/l

0.40

Injury, poisoning and certain other consequences of external causes

378

1342

1.42

8.55

1.5

1.4

4081.68

2355.60

e6/l

0.35

271

935

Other and unspecified disorders of white blood cells

200

2.55

8.52

1.6

1.4

1882.50

6008.14

e6/l

0.46

140

Dissection of aorta

171

2.69

8.52

1.5

1.3

4645.27

1703.93

e6/l

0.68

123

Childhood asthma (age<16), excluding more controls

7.45

8.52

1.4

1.1

3378.08

3121.23

e6/l

0.06

Pain (limb, back, neck, head abdominally)

577

2194

1.32

8.47

1.5

2521.82

3616.29

e6/l

0.78

397

1567

Unspecific neurodegenerative disorder

287

2821

0.69

8.44

1.3

1.5

3160.67

2444.48

e6/l

0.32

206

1989

Other nutritional deficiencies

452

3069

1.35

8.42

1.5

4905.14

3432.36

e6/l

0.29

326

2132

Dementia in Alzheimer disease

1498

0.54

8.41

1.3

1.5

1279.97

2423.08

e6/l

1.08

1069

Pyogenic arthritis

387

2.07

8.34

1.5

1.4

2915.49

4685.12

e6/l

0.30

278

Other noninfective gastroenteritis and colitis

199

1277

1.57

8.29

1.4

1.5

3218.31

2929.72

e6/l

0.08

134

890

Noninfectious colitis NAS

114

633

1.81

8.26

1.4

1.5

3202.90

3451.74

e6/l

0.05

446

Volvulus

151

2.78

8.25

1.4

4037.79

1273.56

e6/l

0.55

Presence of other functional implants

524

2719

1.32

8.25

1.5

1967.64

3655.68

e6/l

1.54

370

1893

Fracture of shoulder and upper arm

310

2177

1.43

8.24

1.4

1.5

5093.35

2952.63

e6/l

0.32

231

1515

Drug-induced osteoporosis with pathological fracture

4.01

8.22

1.7

1.2

1446.12

1799.76

e6/l

0.32

Retinal vascular disorders

140

828

1.71

8.19

1.4

1.5

1062.57

3058.85

e6/l

1.15

100

576

Other symptoms and signs involving cognitive functions and awareness

464

3085

1.34

8.17

1.5

3566.16

2484.28

e6/l

0.46

325

2187

Gangrene, not elsewhere classified

6.62

8.16

1.6

1.3

2922.67

1666.05

e6/l

0.25

Acute myeloid leukaemia and myelodysplastic syndromes

103

3.18

8.16

1.4

1526.71

1518.37

e6/l

0.01

Retinal vascular occlusion

138

814

1.71

8.16

1.4

1.5

1076.86

3096.73

e6/l

1.14

566

Smoking dependency

370

2.08

8.15

1.3

1.5

7220.95

4541.42

e6/l

0.25

261

Mental and behavioural disorders due to tobacco

370

2.08

8.15

1.3

1.5

7220.95

4501.56

e6/l

0.25

265

Acute posthaemorrhagic anaemia

187

2.56

8.12

1.1

1.4

1427.12

1423.74

e6/l

0.00

127

Statin medication

422

1737

1.37

8.12

1.5

1.4

4130.47

3963.87

e6/l

0.03

297

1246

Alcohol-induced chronic pancreatitis

305

2.19

8.12

1.6

1.5

17726.63

4363.75

e6/l

0.37

221

Pulmonary oedema

109

3.12

8.09

1.6

1.3

607.64

1396.16

e6/l

1.97

Colon adenocarcinoma

108

594

1.83

8.09

1.4

1.5

1229.31

2536.48

e6/l

1.66

423

Congenital malformations, deformations and chromosomal abnormalities

343

2331

1.40

8.07

1.6

1.4

3864.32

3526.80

e6/l

0.06

248

1599

Other (seronegative) rheumatoid arthritis, wide

165

1024

1.62

7.99

1.5

1.4

3964.24

3021.81

e6/l

0.28

119

712

Chronic periodontitis, including avohilmo

775

3949

1.25

7.99

1.5

3923.37

3129.67

e6/l

0.34

515

2798

Poisoning by medicine

123

706

1.75

7.96

1.4

9043.26

3630.84

e6/l

0.61

490

Need for immunization against other single viral diseases

3.78

7.96

1.6

1.4

913.33

2053.98

e6/l

1.65

Unspecified protein-energy malnutrition

7.42

7.95

1.2

8487.46

1403.35

e6/l

0.42

Chronic apical periodontitis

852

3850

1.24

7.93

1.5

4864.61

3014.32

e6/l

0.57

581

2714

Amputation of ankle bones

138

2.83

7.90

1.5

1.4

710.69

1670.13

e6/l

2.54

Other disorders of veins

317

2221

1.41

7.86

1.5

1892.61

3391.96

e6/l

1.82

203

1576

Obesity due to excess calories

307

2178

1.41

7.79

1.5

3095.93

3766.51

e6/l

0.20

230

1501

Other renal tubulo-interstitial diseases

3.70

7.77

1.4

1.3

1801.88

1828.87

e6/l

0.01

Intracranial injury

479

3391

1.32

7.77

1.5

3079.19

2880.01

e6/l

0.08

350

2387

Acquired haemolytic anaemia

117

2.98

7.77

1.6

1.3

784.86

1593.83

e6/l

1.37

Injuries to the knee and lower leg

907

3986

1.23

7.74

1.5

2721.05

3428.86

e6/l

0.38

622

2816

Polyarteritis nodosa and related conditions

4.44

7.74

1.4

3987.50

2000.81

e6/l

0.51

Mental and behavioural disorders due to cannabinoids

6.41

7.72

1.3

1.4

16975.22

3005.59

e6/l

—

Protozoal diseases

140

2.77

7.66

1.6

1.4

2303.14

1629.30

e6/l

0.42

Malignant neoplasm of small intestine, including Hilmo

107

3.05

7.66

1.7

1.4

7693.00

1729.99

e6/l

0.41

Open wound of ankle and foot

448

1.94

7.65

1.5

1.4

2733.68

3726.75

e6/l

0.17

310

Use of disulfiram, acamprosate or naltrexone

306

2.14

7.62

1.8

1.5

5780.86

4997.47

e6/l

0.08

211

Periodontitis

772

3950

1.25

7.62

1.5

3931.18

3203.06

e6/l

0.31

514

2798

Personality disorders, excluding more controls

123

714

1.72

7.59

1.5

1.4

14838.53

3842.54

e6/l

0.70

488

Malignant neoplasm of corpus uteri, including Hilmo

288

2.17

7.52

1.3

1.4

1233.64

1747.01

e6/l

0.42

207

Malignant neoplasm of endocrine gland

188

2.47

7.49

1.5

2802.12

2333.46

e6/l

0.11

136

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

465

1.90

7.48

1.4

12256.67

4418.34

e6/l

0.62

319

Protozoal diseases, including avohilmo

142

2.73

7.46

1.6

1.3

2303.14

1653.97

e6/l

0.40

Complications of internal orthopaedic prosthetic devices, implants and grafts

215

1441

1.50

7.43

1.5

1.4

1998.19

3313.04

e6/l

0.89

135

1005

Any mental disorder

834

3377

1.24

7.43

1.5

5081.94

2349.21

e6/l

1.20

592

2355

Malignant neoplasm of retroperitoneum and peritoneum

8.72

7.41

2.2

1.0

634.75

2168.62

e6/l

—

Right bundle-branch block

109

2.97

7.41

1.8

1.2

1790.73

10803.03

e6/l

0.58

Respiratory conditions due to other external agents

3.11

7.38

1.4

1.3

1409.00

1511.38

e6/l

0.08

Disorder of lipoprotein metabolism, unspecified

135

815

1.67

7.35

1.5

1358.77

2286.90

e6/l

1.39

577

Mental and behavioural disorders due to sedatives or hypnotics

190

2.44

7.33

1.4

14831.84

1715.56

e6/l

0.57

128

Persons with potential health hazards related to communicable diseases

180

1152

1.55

7.33

1.5

1.4

11640.54

3485.80

e6/l

0.55

797

Alcohol withdrawal state with delirium

352

2.04

7.32

1.5

19054.96

3940.03

e6/l

0.49

256

Suicide or other Intentional self-harm

146

899

1.63

7.31

1.4

7938.44

3306.90

e6/l

0.66

108

623

Finngen Rheumatological endpoints

678

3053

1.26

7.30

1.5

1.4

2297.54

3877.42

e6/l

1.74

460

2142

Postmenopausal atrophic vaginitis

767

0.52

7.27

1.3

1.4

1734.41

3458.94

e6/l

0.90

535

Psychiatric diseases

760

3059

1.25

7.18

1.5

3834.55

2432.41

e6/l

0.77

530

2134

Other metabolic disorders

458

1.89

7.17

1.6

1.4

1308.81

2703.96

e6/l

2.32

322

Respiratory tuberculosis, confirmed, including avohilmo

101

3.05

7.15

1.5

1.2

2010.47

1460.60

e6/l

0.66

Restrictive cardiomyopathy

8.35

7.14

2.0

1.5

464.80

1016.36

e6/l

—

Unspecified misadventure during surgical and medical care

282

2.16

7.13

1.6

1.5

1355.44

4787.88

e6/l

0.56

194

Cholelithiasis

673

3667

1.26

7.11

1.5

1970.54

2932.76

e6/l

1.28

480

2584

Covid-19 suspected case

124

738

1.69

7.09

1.6

1.5

5561.64

3809.50

e6/l

0.20

518

Other functional intestinal disorders

386

2619

1.34

7.09

1.5

2542.22

3425.92

e6/l

0.55

271

1870

Zoster [herpes zoster]

178

1159

1.55

7.08

1.5

1.4

4869.41

2902.00

e6/l

0.40

128

802

Alzheimer disease, including avohilmo

264

2574

0.71

7.06

1.4

1.5

3291.70

2514.47

e6/l

0.32

191

1816

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

152

954

1.60

7.05

1.4

7929.53

3412.66

e6/l

0.68

113

659

Benign neoplasm: Ascending colon

147

918

1.62

7.03

1.7

1.5

2413.02

3138.90

e6/l

0.24

105

642

Sulfonylureas

393

2338

1.34

7.02

1.6

1.5

1636.30

2883.64

e6/l

1.22

291

1673

Thoracic aortic aneurysm

149

934

1.61

7.01

1.4

1.5

3277.07

3526.60

e6/l

0.07

104

664

Malignant neoplasm of other and unspecified parts of tongue

4.06

6.94

1.7

1.2

881.67

1645.06

e6/l

0.83

Disorders of other endocrine glands

312

2233

1.38

6.88

1.4

1.5

5096.42

3026.65

e6/l

0.54

227

1543

Drug-induced osteoporosis

3.89

6.87

1.7

1.3

4945.46

1792.28

e6/l

0.65

Carcinoma in situ of skin of other and unspecified parts of face

114

673

1.72

6.83

1.6

1.4

2233.43

3331.33

e6/l

0.33

486

Malignant neoplasm of thyroid gland

173

2.45

6.76

1.5

1492.50

2479.82

e6/l

0.62

125

Malignant neoplasm of corpus uteri

268

2.15

6.75

1.2

1.4

1263.41

1811.64

e6/l

0.42

190

Congenital malformations of the urinary system

217

2.28

6.73

1.7

1.4

925.34

2172.60

e6/l

2.34

144

Fall involving bed

212

2.31

6.68

1.2

1.4

1390.90

1305.88

e6/l

0.09

146

Disease of hard tissues of teeth, NOS

281

2043

0.72

6.68

1.5

2865.02

2521.46

e6/l

0.20

179

1447

Tuberculosis, IBD comorbidity

442

1.88

6.67

1.6

1.4

1837.61

3551.06

e6/l

0.41

308

Abnormal findings in nipple discharge synovial fluid wound secretions

4.10

6.67

1.3

695.70

2521.24

e6/l

—

Respiratory tuberculosis, confirmed

100

2.98

6.65

1.5

1.3

2077.39

1460.60

e6/l

0.74

Tubulo-interstitial nephritis, not specified as acute or chronic

310

2.05

6.65

1.5

1.4

1847.33

4528.84

e6/l

0.47

220

Congenital malformations of aortic and mitral valves

139

2.62

6.64

1.5

1.4

2466.68

1841.63

e6/l

0.39

Degeneration of macula and posterior pole

508

3062

1.29

6.64

1.4

1.5

3023.42

2550.98

e6/l

0.13

356

2174

Embolic stroke with flimmer

122

2.75

6.64

1.4

1.3

4049.90

2337.43

e6/l

0.31

Corns and callosities

331

2.02

6.62

1.5

1.4

967.63

4300.73

e6/l

0.69

233

Diseases of the myoneural junction and muscle

121

731

1.67

6.62

1.5

23481.61

1815.36

e6/l

1.43

514

Other and unspecified vascular occlusions

107

626

1.73

6.61

1.5

1184.75

3613.82

e6/l

1.03

441

Arterial embolism and thrombosis

338

2.01

6.61

1.4

1749.19

4447.99

e6/l

0.52

244

Injury of intra-abdominal organs

3.30

6.58

1.3

1.4

3400.81

2077.98

e6/l

0.49

Disorders of magnesium metabolism

5.56

6.58

1.6

1.4

414.75

1371.70

e6/l

1.46

Asthma, including avohilmo

896

4082

1.21

6.54

1.5

1.4

3014.91

3392.34

e6/l

0.26

639

2871

Carcinoma in situ of skin of scalp and neck

221

2.28

6.54

1.6

1.4

1083.39

1495.75

e6/l

0.72

157

Abnormal weight loss

525

1.79

6.51

1.5

1.4

1804.36

3507.58

e6/l

0.48

356

Dependence on enabling machines and devices, not elsewhere classified

5.45

6.50

1.3

1.2

714.22

1462.33

e6/l

—

Diabetic neuropathy

128

785

1.64

6.50

1.6

1.5

711.90

3264.63

e6/l

1.52

534

Delirium, not induced by alcohol and other psychoactive substances

152

974

1.57

6.49

1.5

4827.01

2511.59

e6/l

0.54

104

699

Renal cell carcinoma of kidney

141

2.60

6.48

1.4

1.5

1986.00

1446.28

e6/l

0.27

100

L01XX Other antineoplastic agents

355

1.97

6.48

1.4

1975.54

4107.40

e6/l

0.41

248

Intestinal malabsorption

178

2.39

6.40

2.0

1.3

4049.57

1941.17

e6/l

0.34

111

Other reaction to severe stress, and adjustment disorders

181

1209

1.50

6.36

1.5

1.4

6214.14

3772.41

e6/l

0.38

130

818

Polycystic kidney disease

2.94

6.35

1.6

1.4

1103.22

2027.16

e6/l

0.98

Pneumonitis due to solids and liquids

559

1.75

6.35

1.5

1.4

1371.88

3412.51

e6/l

0.71

394

Ventricular septal defect, a heart condition

4.09

6.34

2.1

1.3

994.42

3622.52

e6/l

1.01

Adenocarcinoma of pancreas

131

2.64

6.34

1.4

1.5

8041.85

1552.89

e6/l

0.62

Assault

385

1.91

6.31

1.5

1.4

5859.34

4652.35

e6/l

0.16

265

Sequelae of other external causes

256

2.13

6.31

1.6

1.4

1295.49

1661.53

e6/l

0.43

174

Congenital malformations of the urinary system, including avohilmo

237

2.17

6.26

1.7

1.4

988.33

5932.53

e6/l

0.69

157

Malignant neoplasm of thyroid gland, including Hilmo

192

2.31

6.26

1.5

1460.48

2380.67

e6/l

0.63

138

Urinary track infection

289

1038

1.40

6.24

1.4

2076.37

3204.90

e6/l

0.64

196

732

Anorexia

5.12

6.22

1.6

1.3

7921.08

1972.60

e6/l

0.68

Procreative management

167

903

1.53

6.22

1.5

1.4

2517.50

4283.45

e6/l

0.80

111

629

Osteonecrosis due to drugs

3.29

6.21

1.2

1.3

7717.80

1650.79

e6/l

0.67

Abscess of anal and rectal regions

318

2.00

6.21

1.3

1.4

2151.00

4721.52

e6/l

0.44

218

Other neurological diseases

633

3966

1.24

6.21

1.4

1.5

1656.51

3310.00

e6/l

3.19

468

2786

ILD-related respiratory insufficiency

226

2.21

6.19

1.4

8977.86

5427.58

e6/l

0.18

156

Multiple myeloma and malignant plasma cell neoplasms

306

2.03

6.18

1.4

1177.31

4419.31

e6/l

0.59

215

Caries of enamel

428

3605

0.77

6.17

1.5

1.4

4647.76

3511.18

e6/l

0.26

260

2544

Low back pain

581

3133

1.25

6.17

1.4

1.5

3895.63

2939.24

e6/l

0.49

415

2198

Triptan medication for migraine, single purchase ok

232

2209

0.71

6.14

1.4

3499.52

3916.59

e6/l

0.16

159

1515

Migraine, single triptan purchase ok & required. ICD-code if available is included

232

2209

0.71

6.14

1.4

3499.52

3916.59

e6/l

0.16

159

1515

Right hemicolectomy

362

1.93

6.14

1.3

1.5

1009.02

4018.73

e6/l

0.66

252

Follicular lymphoma, hilmo

240

2.16

6.12

1.5

1.4

1983.56

5361.04

e6/l

0.44

164

Other menopausal disorders

705

0.54

6.11

1.4

2736.11

3740.32

e6/l

0.37

488

Multiple myeloma

122

2.67

6.10

1.3

1.5

1170.64

1701.36

e6/l

0.62

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

122

2.67

6.10

1.3

1.5

1170.64

1701.36

e6/l

0.62

Cystic kidney disease

122

2.67

6.09

1.6

1.4

1010.35

1776.38

e6/l

0.91

Exposure to other specified factors

558

3832

1.25

6.06

1.4

1.5

7031.09

3030.06

e6/l

1.06

385

2693

Chronic diseases of tonsils and adenoids

299

2541

0.74

6.01

1.4

3297.85

3840.24

e6/l

0.28

213

1780

Respiratory tuberculosis, bacteriologically and histologically confirmed

106

2.80

6.01

1.5

1.3

2077.39

1421.14

e6/l

0.83

Spondyloarthritis

140

898

1.57

6.01

1.5

11916.27

3435.04

e6/l

0.61

102

636

Left ventricular outflow tract obstruction, narrow definition

165

2.39

5.98

1.5

2518.53

1857.64

e6/l

0.45

110

Other and unspecified coagulation defects

147

2.47

5.95

1.6

1.3

1270.15

2043.40

e6/l

1.25

Neurological diseases, wide definition

145

458

1.59

5.94

1.4

2346.83

3549.37

e6/l

0.36

312

Gonarthrosis, primary, with knee surgery

355

3613

0.76

5.92

1.5

1910.45

3189.30

e6/l

1.97

250

2546

Transient ischemic attack

499

3148

1.27

5.90

1.4

1.5

1663.52

3247.69

e6/l

2.32

377

2211

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.92

5.90

1.4

1975.38

1987.74

e6/l

0.01

Malignant neoplasm of liver and intrahepatic bile ducts

148

2.47

5.90

2.0

1.4

1509.19

1371.60

e6/l

0.07

103

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

127

790

1.59

5.89

1.6

1.4

7379.29

3274.92

e6/l

0.68

103

544

Other and unspecified immunodeficiencies with predominantly antibody defects

5.92

5.88

1.3

1.2

855.25

2110.57

e6/l

—

Malignant neoplasm of bladder

381

1.88

5.88

1.3

1.5

1239.35

1922.55

e6/l

0.54

281

Benign neoplasm: Rectum

176

1194

1.48

5.86

1.5

1373.10

3101.32

e6/l

1.45

116

836

Use of donepezil

123

1830

0.64

5.85

1.3

1.5

3433.66

2770.84

e6/l

0.18

101

1279

Alcohol abuse, main dg, excluding more controls

106

640

1.67

5.85

1.4

1.5

3075.57

3831.15

e6/l

0.18

442

Acute nephritic syndrome

3.06

5.84

1.6

1.3

1078.65

2143.39

e6/l

1.03

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

197

2185

0.70

5.82

1.4

1.5

3898.16

3214.31

e6/l

0.14

147

1522

Disorders of parathyroid gland

185

1254

1.47

5.80

1.4

4516.38

3370.98

e6/l

0.20

138

877

Spondylopathies in diseases classified elsewhere

3.43

5.78

1.3

1.4

684.27

1532.68

e6/l

1.48

Other and unspecified acquired haemolytic anaemias

4.04

5.77

1.8

1.3

630.11

1709.81

e6/l

—

Malignant neoplasm of larynx

3.31

5.77

1.4

1.5

6532.14

1858.00

e6/l

0.53

Soft tissue disorders

746

3144

1.22

5.76

1.5

1.4

2819.87

3139.37

e6/l

0.20

513

2216

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

374

2614

1.31

5.76

1.6

1.4

4073.76

3777.77

e6/l

0.06

267

1805

Familial hypercholesterolemia

150

990

1.53

5.71

1.6

1.5

6302.59

2314.14

e6/l

0.38

125

703

151

2.44

5.69

1.3

1.4

1619.42

1395.29

e6/l

0.15

101

Degeneration of the brain due to alcohol

121

2.62

5.68

1.6

1.4

24150.17

1293.82

e6/l

0.76

Obesity

404

2959

1.29

5.64

1.5

2987.32

3730.68

e6/l

0.29

292

2051

Benign neoplasm: Rectum, anus and anal canal

196

1368

1.44

5.64

1.5

1522.64

2972.48

e6/l

1.32

129

957

Haemolytic anaemias

164

2.35

5.62

1.6

1.4

816.79

1694.15

e6/l

1.95

111

Pleural plaque without asbestos

277

2.03

5.57

1.3

1.5

7757.56

1474.88

e6/l

0.50

193

Fracture of foot, except ankle

154

1027

1.51

5.56

1.5

1.4

2739.96

3411.95

e6/l

0.25

101

705

Umbilical hernia

218

1556

1.41

5.52

1.4

1.5

3108.50

4265.08

e6/l

0.44

149

1085

Epilepsy

254

1854

1.37

5.51

1.4

1.5

4215.25

3710.27

e6/l

0.09

194

1280

Obesity and other hyperalimentation

405

2974

1.28

5.49

1.5

2987.32

3720.22

e6/l

0.28

292

2061

Organ-limited amyloidosis

5.95

5.49

1.2

1.4

636.56

900.89

e6/l

—

Other specified disorders of kidney and ureter

141

2.45

5.49

1.2

1.3

2316.41

1642.74

e6/l

0.16

Cystic kidney disease, including avohilmo

141

2.45

5.48

1.7

1.4

1094.25

1730.24

e6/l

0.79

Other diseases of stomach and duodenum

355

1.88

5.47

1.7

1.4

1678.05

4266.19

e6/l

0.50

249

Essential (haemorrhagic) thrombocythaemia

129

2.51

5.47

1.3

1.4

1395.04

1548.19

e6/l

0.14

Intestinal adhesions without obstruction

464

1.76

5.46

1.4

3856.25

3620.64

e6/l

0.03

325

Exposure to other and unspecified inanimate mechanical forces

278

1.99

5.45

1.6

1.5

1825.91

1810.89

e6/l

0.01

195

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

120

761

1.59

5.45

1.4

1.5

1241.81

3583.50

e6/l

1.30

544

Malignant neoplasm of rectum

442

1.78

5.44

1.5

910.41

2674.03

e6/l

2.01

318

Degeneration of nervous system due to alcohol

124

2.56

5.42

1.6

1.4

24150.17

1441.28

e6/l

0.75

Alcohol induced polyneuropathy

3.84

5.42

1.6

1.4

2848.82

1983.62

e6/l

0.16

Tuberculosis, wide

473

1.75

5.42

1.6

1.4

1837.61

3384.69

e6/l

0.39

332

Persons encountering health services in other circumstances

284

2098

1.34

5.41

1.4

2707.67

3353.10

e6/l

0.28

206

1511

Noninfective enteritis and colitis

323

2456

1.32

5.39

1.4

1.5

2621.61

3429.69

e6/l

0.42

228

1701

Malignant immunoproliferative diseases

3.52

5.37

1.9

1.3

677.08

1861.71

e6/l

1.94

Malignant neoplasm of larynx, including Hilmo

2.83

5.34

1.4

1.5

5718.24

1578.52

e6/l

0.59

Cyst of kidney

416

1.80

5.34

1.6

1.4

1293.87

3854.26

e6/l

0.63

287

Alzheimer disease

241

2342

0.73

5.32

1.4

1.5

3605.82

2588.34

e6/l

0.39

170

1654

Malignant neoplasm of rectum, including Hilmo

550

1.68

5.32

1.4

1.5

1067.71

2712.63

e6/l

2.10

397

Tuberculosis, wide, including avohilmo

476

1.74

5.31

1.6

1.4

1837.61

3369.26

e6/l

0.39

334

Other diseases of urinary system

761

3560

1.20

5.29

1.5

2576.02

3350.44

e6/l

0.65

529

2548

Benign neoplasm: Sigmoid colon

180

1254

1.44

5.27

1.5

1991.99

3026.39

e6/l

0.64

128

869

Extreme obesity with alveolar hypoventilation

169

2.28

5.26

1.4

4311.10

1570.23

e6/l

0.80

110

Other and unspecified injuries of head

367

1.84

5.25

1.4

15887.31

4198.52

e6/l

0.35

254

Sequelae of injuries of neck and trunk

108

2.63

5.25

1.6

1.5

5268.23

1827.62

e6/l

0.46

Hypercalcemia

242

2.05

5.23

1.5

1.3

1302.24

1548.17

e6/l

0.28

167

Injuries to unspecified part of trunk, limb or body region

500

1.71

5.23

1.7

1.4

1510.70

3542.70

e6/l

0.59

353

Disorders of continuity of bone

375

1.83

5.21

1.5

1.4

3375.08

4631.37

e6/l

0.19

262

Complications following infusion, transfusion and therapeutic injection

3.41

5.20

1.8

1.3

2823.33

1758.51

e6/l

0.37

Listeriosis

6.00

5.17

1.8

1.3

1202.00

1589.06

e6/l

—

Listeriosis, including avohilmo

5.99

5.16

1.8

1.3

1202.00

1589.06

e6/l

—

Other symptoms and signs involving the digestive system and abdomen

117

749

1.57

5.14

1.5

1.4

1825.46

3916.65

e6/l

0.73

514

Diseases of pulp and periapical tissues, including avohilmo

801

3476

1.19

5.11

1.5

3511.07

2796.33

e6/l

0.26

562

2439

malignant neoplasm of male genital organs

230

1000

1.39

5.07

1.5

2084.27

3888.40

e6/l

0.89

161

719

Other disorders of urethra and urinary system

556

3151

1.23

5.07

1.5

2529.78

3175.89

e6/l

0.45

380

2264

Benign thyroid growths and nodules

247

1697

1.36

5.03

1.4

2579.18

3550.11

e6/l

0.49

170

1186

Myeloproliferative diseases

469

1.72

5.02

1.3

1.4

1862.71

3583.37

e6/l

0.43

323

Carbimazole or st.post thyroidectomy, condition for graves disease

131

866

1.52

4.99

1.5

1.4

1653.39

3259.16

e6/l

0.87

597

Abnormalities of gait and mobility

122

796

1.55

4.97

1.4

1.5

2300.94

3093.33

e6/l

0.22

555

Inflammatory diseases of the central nervous system

360

1.82

4.94

1.3

1.4

2095.96

4236.64

e6/l

0.40

250

Hernia of abdominal wall

371

2916

1.28

4.92

1.4

1.5

3418.69

3456.63

e6/l

0.01

259

2051

Primary gonarthrosis, bilateral

317

3426

0.77

4.92

1.4

1.5

2127.87

3151.37

e6/l

1.17

235

2414

Mycoses, including avohilmo

660

4181

1.20

4.91

1.5

2921.52

3489.29

e6/l

0.29

443

2950

Unspecified nephritic syndrome

2.82

4.91

1.7

1.3

808.12

2043.30

e6/l

2.07

Other and unspecified nonorganic psychotic disorders

593

1.62

4.90

1.5

1.4

3403.27

4030.83

e6/l

0.14

416

Thiazolidinediones

113

728

1.57

4.88

1.7

1.5

1166.65

1978.35

e6/l

1.36

516

Obesity, other/unspecified

189

1347

1.41

4.87

1.7

1.5

4196.55

3347.43

e6/l

0.15

130

917

Diseases of the eye and adnexa

477

1913

1.25

4.85

1.5

2467.69

3824.51

e6/l

1.17

340

1344

Adenocarcinoma and papilloma adenocarcinoma of rectum

436

1.73

4.84

1.5

894.96

2711.28

e6/l

2.03

310

Emotionally unstable personality disorder

228

2.03

4.84

1.8

1.4

4381.87

3084.74

e6/l

0.32

154

Dental pulpitis, including avohilmo

380

3078

0.79

4.84

1.5

4362.00

3904.79

e6/l

0.14

266

2143

Other spirochaetal diseases

123

1839

0.67

4.83

1.4

1.5

2934.40

3158.93

e6/l

0.06

1285

Personal history of other diseases and conditions

227

2.02

4.83

1.6

1.4

1787.40

2729.13

e6/l

0.63

147

Myeloid leukaemia

138

2.36

4.79

1.5

1.4

1951.85

1498.44

e6/l

0.44

Dementia

319

2809

0.77

4.79

1.3

1.5

2858.51

2397.95

e6/l

0.24

232

1974

Injuries to the elbow and forearm

488

3394

1.23

4.77

1.4

1.5

6651.35

3013.18

e6/l

0.79

344

2360

Schizophrenia or delusion, excluding more controls

173

1203

1.42

4.77

1.5

1.4

5335.27

3130.34

e6/l

0.59

114

813

Other spirochaetal diseases, including avohilmo

125

1857

0.67

4.76

1.5

2907.70

3238.74

e6/l

0.09

1298

Other systemic involvement of connective tissue (FG)

205

1461

1.38

4.75

1.4

3935.14

3306.58

e6/l

0.16

132

1018

Methotrexate

607

1.61

4.73

1.5

1.4

2925.99

3699.43

e6/l

0.20

410

Other necrotizing vasculopathies

410

1.75

4.72

1.6

1.5

1525.53

3637.89

e6/l

0.49

286

Follow-up examination after treatment for conditions other than malignant neoplasms

300

1524

1.31

4.72

1.5

1.4

5109.79

2944.21

e6/l

0.29

206

1014

Specific personality disorders

109

701

1.56

4.72

1.6

1.4

4063.61

3816.77

e6/l

0.05

488

Other noninfective disorders of lymphatic vessels and lymph nodes

139

2.33

4.70

1.7

1.4

1461.70

1786.94

e6/l

0.27

Spirochaetal infections, other/unspecified, including avohilmo

124

1839

0.67

4.69

1.5

2907.70

3154.01

e6/l

0.07

1286

Disorders of adult personality and behaviour

130

870

1.50

4.69

1.5

1.4

14479.52

3751.61

e6/l

0.71

605

Abdominal aortic aneurysm (AAA)

120

785

1.53

4.68

1.4

2649.81

3329.75

e6/l

0.17

567

Colectomy operation

154

1068

1.45

4.67

1.3

1.5

1786.55

2997.29

e6/l

0.73

105

754

Osteopathy in diseases classified elsewhere

5.65

4.65

1.7

1.3

1086.14

3571.77

e6/l

—

Personal history of medical treatment

3.58

4.65

1.6

1.3

4330.10

1384.62

e6/l

—

Lyme disease

123

1824

0.67

4.65

1.4

1.5

2934.40

3170.29

e6/l

0.06

1277

Lyme disease, including avohilmo

123

1824

0.67

4.65

1.4

1.5

2934.40

3170.29

e6/l

0.06

1277

Supplementary factors related to causes of morbidity and mortality classified elsewhere

223

1648

1.36

4.64

1.5

5623.14

2959.73

e6/l

0.32

182

1129

Dementia, including avohilmo

345

2985

0.78

4.60

1.3

1.5

3274.06

2391.22

e6/l

0.45

253

2093

Symptoms and signs involving the skin and subcutaneous tissue

530

4119

1.22

4.59

1.5

3621.17

3260.28

e6/l

0.11

386

2874

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

459

1.69

4.56

1.5

881.16

2649.13

e6/l

2.08

324

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

376

2882

1.26

4.53

1.5

4087.17

3464.81

e6/l

0.22

265

2028

Hyperparathyroidism

161

1120

1.43

4.52

1.4

2770.79

3629.27

e6/l

0.25

117

773

Malignant neoplasm of prostate

226

984

1.36

4.49

1.5

2050.36

3894.74

e6/l

0.90

159

709

Dronedarone medication

2.62

4.49

1.6

1.3

883.47

12913.72

e6/l

0.59

Vitamin deficiency

208

2.04

4.48

1.3

1.4

1508.20

1565.73

e6/l

0.04

140

Vitamin deficiency, wide

208

2.04

4.48

1.3

1.4

1508.20

1565.73

e6/l

0.04

140

Panic disorder

349

1.78

4.48

1.5

1.4

2497.20

3016.62

e6/l

0.29

240

Diseases of the musculoskeletal system and connective tissue

349

1364

1.29

4.47

1.5

1.4

4846.37

3284.44

e6/l

0.26

242

956

Congenital malformations of great arteries

4.15

4.44

1.5

1.4

3422.00

1944.13

e6/l

—

Other diseases of oesophagus

563

1.61

4.44

1.9

1.4

5373.16

3212.27

e6/l

0.35

392

Gastro-oesophageal reflux disease

498

3445

1.22

4.43

1.5

1.4

4649.57

3004.30

e6/l

0.39

364

2434

Primary Sclerosing Cholangitis, IBD and UDCA required

3.04

4.41

1.2

1.3

861.25

2105.22

e6/l

1.93

Spondylopathies

627

3098

1.20

4.37

1.5

6049.94

2686.83

e6/l

0.91

445

2179

Dermatophytosis

118

789

1.50

4.34

1.5

1742.77

3304.93

e6/l

0.69

561

Familial hypercholesterolemia, with ischemic heart disease

638

1.57

4.33

1.7

1.5

8740.65

2388.17

e6/l

0.40

453

Assault by bodily force

171

2.12

4.28

1.3

1.4

7216.22

2495.12

e6/l

0.95

116

Glaucoma secondary to other eye disorders

219

1.99

4.28

1.3

1.4

1330.03

1521.05

e6/l

0.15

153

Tuberculosis

408

1.71

4.26

1.5

1.4

1793.77

3652.71

e6/l

0.42

291

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

131

898

1.47

4.24

1.4

1.5

1351.70

3470.05

e6/l

1.37

633

Alcohol abuse, main dg

106

696

1.53

4.24

1.4

1.5

3075.57

3829.56

e6/l

0.19

481

Idiopathic pulmonary fibrosis

580

1.59

4.20

1.6

1.4

6072.77

2991.11

e6/l

0.34

413

Myocardial infarction, unclassifiable

251

1712

1.32

4.19

1.4

1.5

2964.74

2618.42

e6/l

0.08

188

1213

Unknown and unspecified causes of morbidity

284

1.84

4.19

1.4

1654.14

5065.82

e6/l

0.57

200

Respiratory tuberculosis, confirmed and not-confirmed

351

1.76

4.16

1.5

1.4

1820.27

4133.43

e6/l

0.46

250

Respiratory tuberculosis

351

1.76

4.16

1.5

1.4

1820.27

4133.43

e6/l

0.46

250

Personality disorders

123

836

1.48

4.16

1.5

1.4

14838.53

3849.14

e6/l

0.70

573

Other localized connective tissue disorders

3.03

4.14

1.5

1.3

1820.30

1847.67

e6/l

—

Hepatocellular carcinoma, including Hilmo

141

2.23

4.14

2.0

1.4

1632.65

1362.95

e6/l

0.12

Other and unspecified effects of external causes

151

1068

1.42

4.14

1.5

1.4

2686.65

3378.41

e6/l

0.26

101

733

Postprocedural endocrine and metabolic disorders, not elsewhere classified

411

1.69

4.13

1.5

1.4

1313.45

2709.03

e6/l

1.97

285

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.00

4.13

1.4

2683.36

2830.32

e6/l

0.04

Other and unspecified injuries of lower leg

264

1.87

4.12

1.4

1850.75

2355.03

e6/l

0.26

186

Actinic keratosis

400

2948

1.24

4.11

1.5

3456.46

2436.44

e6/l

0.25

268

2089

Cerebral palsy and other paralytic syndromes

535

1.60

4.11

1.7

1.5

3132.94

3746.80

e6/l

0.11

374

Amputation of thigh

209

1.99

4.09

1.8

1.4

766.54

1376.24

e6/l

1.63

149

malignant neoplasm of male genital organs, including Hilmo

225

1010

1.34

4.09

1.4

1.5

2093.19

3888.58

e6/l

0.88

158

727

Fracture of forearm

374

2701

1.25

4.09

1.4

4867.88

2742.11

e6/l

0.49

259

1870

Drug-induced cataract

2.66

4.08

1.7

1.3

2346.25

1980.73

e6/l

0.15

Other systemic involvement of connective tissue

209

1566

1.34

4.04

1.4

1.5

3844.13

3072.45

e6/l

0.22

136

1086

Malignant neoplasm of prostate, including Hilmo

225

994

1.34

4.04

1.4

1.5

2099.08

3896.68

e6/l

0.87

159

717

Degenerative diseases of the nervous system

279

2563

0.78

4.02

1.4

1.5

5550.48

2535.29

e6/l

0.76

196

1813

Spinal stenosis

470

2852

1.22

4.02

1.4

4203.35

2580.08

e6/l

0.42

341

2016

Viral and other specified intestinal infections

100

640

1.53

4.01

1.4

1.5

1918.27

3709.95

e6/l

0.67

444

Lower back pain or/and sciatica

784

4186

1.17

3.99

1.4

1.5

4001.23

3203.99

e6/l

0.42

557

2939

Focal epilepsy

159

1144

1.40

3.97

1.4

1.5

2352.65

3143.83

e6/l

0.43

127

793

Type of accident

206

1546

1.34

3.95

1.5

5895.59

3039.02

e6/l

0.32

167

1062

Phobic anxiety disorders

267

1.84

3.94

1.3

1.4

2116.35

3551.55

e6/l

0.91

180

Other coagulation defects

305

1.78

3.93

1.5

1.4

6517.42

1812.42

e6/l

0.43

210

Injury of unspecified body region

380

1.70

3.91

1.8

1.4

1576.13

3905.25

e6/l

0.49

266

Diseases of pulp and periapical tissues and dental caries

567

2431

1.20

3.90

1.5

4234.94

2386.68

e6/l

0.58

394

1736

Other surgical follow-up care

100

2.42

3.90

1.3

17170.42

1800.40

e6/l

0.47

Alzheimer’s disease, strict definition

189

2038

0.74

3.89

1.4

1.5

3634.35

2648.41

e6/l

0.30

127

1444

Adenocarcinoma and papillary adenocarcinoma of stomach

119

2.30

3.89

1.3

1.4

2063.68

1429.68

e6/l

0.27

Other and unspecified myopathies

536

1.58

3.87

1.5

1.4

28234.61

1856.39

e6/l

1.21

377

Neovascular glaucoma

214

1.94

3.84

1.3

1.4

1398.35

1531.59

e6/l

0.10

152

418

3085

1.22

3.83

1.5

3372.68

2432.61

e6/l

0.24

279

2184

Poisoning by narcotics and psychodysleptics [hallucinogens]

4.34

3.83

1.3

1448.40

1991.62

e6/l

—

CR(E)ST syndrome

3.12

3.83

1.5

1.3

956.63

1756.65

e6/l

—

Carcinoma in situ of skin

562

1.56

3.82

1.4

1584.88

3570.06

e6/l

0.67

394

Injuries to the shoulder and upper arm

648

4260

1.17

3.80

1.5

4914.79

3027.44

e6/l

0.55

456

2993

Postprocedural disorders of digestive system, not elsewhere classified

153

2.12

3.80

1.3

1.4

5838.14

1617.82

e6/l

0.40

Dorsalgia

704

3187

1.17

3.78

1.5

3419.79

2908.09

e6/l

0.27

483

2239

Other skin changes

171

1258

1.37

3.77

1.4

1.5

5882.46

3034.39

e6/l

0.36

131

870

Paracetamol or NSAID medication

117

397

1.49

3.75

1.3

1.5

1976.74

2041.24

e6/l

0.05

286

Barrett oesophagus

266

1.82

3.75

1.5

1.4

6953.06

5246.52

e6/l

0.12

183

Skin changes due to chronic exposure to nonionizing radiation

403

2992

1.22

3.73

1.5

1.4

3438.32

2448.59

e6/l

0.25

271

2119

Congenital malformations of the respiratory system, including avohilmo

2.83

3.70

1.8

1.4

2914.91

1765.51

e6/l

0.28

Fracture of neck

349

1.71

3.69

1.6

1.4

3070.12

4054.80

e6/l

0.12

244

Arterial embolism and thrombosis of lower extremity artery

196

1.96

3.69

1.5

1.4

2008.11

5824.19

e6/l

0.41

142

Tetraplegia

4.54

3.66

1.4

1.2

1749.00

1724.93

e6/l

—

Osteoporosis with pathological fracture (FG)

442

1.62

3.65

1.4

2945.51

3190.54

e6/l

0.04

308

Polycythaemia vera

129

2.20

3.65

1.1

1.5

2383.06

1562.94

e6/l

0.34

Contraceptive management

920

0.66

3.64

1.6

1.4

3893.00

4380.47

e6/l

0.10

641

Malignant neoplasm of floor of mouth, including Hilmo

4.12

3.63

1.1

1.2

1013.57

1749.74

e6/l

—

Melanocytic naevi of trunk

521

1.56

3.62

1.5

1.4

1168.31

3812.26

e6/l

0.90

363

Infective dermatitis

593

1.53

3.62

1.6

1.4

2572.74

3820.50

e6/l

0.35

414

Type 1 diabetes, strict (exclude DM2)

176

1.99

3.60

1.4

1593.91

2410.47

e6/l

0.92

116

Type 1 diabetes, definitions combined

176

1.99

3.60

1.4

1593.91

2491.81

e6/l

1.05

117

Alzheimer’s disease (Late onset)

179

1955

0.75

3.56

1.4

1.5

3798.50

2690.06

e6/l

0.32

119

1388

Motorcycle rider injured in noncollision transport accidents

2.59

3.56

1.9

1.4

12579.31

2322.20

e6/l

0.88

Portal vein thrombosis

2.85

3.54

1.5

1.3

3413.00

2132.11

e6/l

—

Other arterial embolism and thrombosis

151

2.08

3.54

1.3

1414.33

1550.16

e6/l

0.09

107

Infection due to other mycobacteria

2.66

3.50

1.3

1772.54

1531.57

e6/l

0.17

Adenocarcinoma and Papillary adenocarcinoma of kidney

2.95

3.50

1.3

1.4

851.20

1920.79

e6/l

—

Hypocalcemia

2.45

3.49

1.3

2533.63

1896.48

e6/l

0.24

Adverse effects, not elsewhere classified

106

728

1.46

3.48

1.5

1.4

1668.89

3748.76

e6/l

0.97

507

Rare circulating lymphoid malignancy

4.71

3.47

2.1

1.3

14345.90

2052.36

e6/l

—

Other inflammatory liver diseases

295

1.74

3.47

1.9

1.4

5861.27

4745.69

e6/l

0.10

204

Localized swelling, mass and lump of skin and subcutaneous tissue

233

1815

1.29

3.46

1.5

3162.74

3014.04

e6/l

0.06

181

1254

Bicuspidal aortic valve syndrome

132

2.14

3.46

1.6

1.4

2658.00

1842.56

e6/l

0.43

Alcohol-induced acute pancreatitis

166

2.01

3.46

1.4

1.5

3836.18

1686.84

e6/l

0.56

113

Overexertion and strenuous or repetitive movements

410

1.62

3.43

1.6

1.5

3982.78

4281.69

e6/l

0.04

288

Carcinoma in situ of skin of lower limb, including hip

133

2.14

3.43

1.5

1.4

1690.38

1276.32

e6/l

0.26

Unspecified jaundice

282

1.75

3.40

1.6

1.3

3543.10

4761.87

e6/l

0.13

193

Abrasion of teeth

127

1760

0.72

3.40

1.4

1.5

1903.12

3407.76

e6/l

1.29

1211

Ulcer of oesophagus

412

1.62

3.39

1.6

1.4

4482.40

3834.95

e6/l

0.07

285

Monoplegia

2.88

3.38

1.7

1.4

1233.67

1547.24

e6/l

—

Retinal detachments and breaks

307

2480

1.24

3.37

1.4

1.5

4471.67

2720.03

e6/l

0.23

211

1742

Other dorsopathies, not elsewhere classified

711

3189

1.16

3.37

1.5

2826.14

2907.20

e6/l

0.05

496

2241

Disorders of eyelid, lacrimal system and orbit

658

4156

1.16

3.37

1.4

1.5

2085.33

3342.50

e6/l

2.07

459

2935

Progressive vascular leukoencephalopathy

291

1.74

3.36

1.3

1.4

1826.50

1715.96

e6/l

0.05

203

Anxiety (asthma-related co-morbidities)

299

1822

1.25

3.36

1.5

1.4

4452.87

3227.88

e6/l

0.35

201

1241

Type 1 diabetes, strict definition, subgroup 1

2.50

3.36

1.3

1.5

2009.10

3460.38

e6/l

—

Disorders of the thyroid gland

692

3882

1.16

3.33

1.5

4059.19

3180.18

e6/l

0.24

479

2738

Other specified and unspecified personality disorders

254

1.78

3.33

1.4

3069.80

2092.37

e6/l

0.35

175

Diseases of salivary glands

211

1633

1.30

3.32

1.4

1.5

3549.79

3151.86

e6/l

0.10

150

1119

Sarcoidosis

631

1.48

3.28

1.8

1.4

1971.08

3549.28

e6/l

0.56

435

Sequelae of injuries, of poisoning and of other consequences of external causes

150

1108

1.36

3.27

1.6

1.5

2432.34

3187.31

e6/l

0.29

104

773

Family history of malignant neoplasm

331

1.67

3.25

1.4

3173.00

2680.30

e6/l

0.21

223

Acute upper respiratory infections of multiple and unspecified sites

515

3187

1.18

3.24

1.5

1.4

2523.46

3892.27

e6/l

1.45

379

2214

Benign neoplasm: Duodenum

143

2.06

3.24

1.4

1.3

1836.25

1687.59

e6/l

0.10

Pregnancy, childbirth and the puerperium

103

772

0.69

3.23

1.4

1656.18

2797.57

e6/l

0.91

549

Oesophageal obstruction

206

1.87

3.23

1.4

1840.67

1892.69

e6/l

0.04

134

Infection due to other mycobacteria, including avohilmo

2.54

3.23

1.3

1772.54

1489.35

e6/l

0.21

Benign neoplasm of other and ill-defined parts of digestive system

143

1052

1.37

3.22

1.6

1.4

1591.59

3092.45

e6/l

1.01

723

Sequelae of injuries of head

206

1.86

3.22

1.5

1.4

1579.75

1785.97

e6/l

0.16

145

Other inflammation of eyelid

103

716

1.45

3.22

1.3

1.5

3557.51

3658.93

e6/l

0.02

497

Other diseases of anus and rectum

248

1960

1.26

3.21

1.5

1693.83

3084.96

e6/l

1.17

188

1394

Schizophrenia, schizotypal and delusional disorders

174

1318

1.32

3.21

1.4

5352.10

3130.85

e6/l

0.62

116

919

Specific development disorders of speech and language

151

1.99

3.19

1.4

16866.41

1770.94

e6/l

0.62

Schizophrenia or delusion

173

1311

1.32

3.18

1.5

1.4

5335.27

3168.58

e6/l

0.59

114

915

Gonarthrosis,primary

578

4052

0.86

3.18

1.5

1994.50

3347.20

e6/l

2.35

414

2853

Abnormal serum enzyme levels

294

2297

1.24

3.18

1.5

1646.02

3167.67

e6/l

1.79

201

1649

Nerve, nerve root and plexus disorders

789

4149

1.14

3.17

1.5

1.4

2649.43

3398.05

e6/l

0.57

585

2891

Other and unspecified haemorrhagic conditions

2.77

3.17

1.1

1.4

3160.10

1908.57

e6/l

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.33

3.17

1.5

1.3

1099.86

1831.59

e6/l

—

Caries of dentine, including avohilmo

644

2837

1.16

3.17

1.5

4047.86

2637.82

e6/l

0.46

436

2028

Inguinal hernia

478

2682

1.19

3.17

1.5

1930.11

3605.90

e6/l

2.01

354

1873

Acute sinusitis

294

2162

1.24

3.15

1.5

2903.35

4436.26

e6/l

0.88

214

1473

Papillary adenocarcinoma of thyroid gland

124

2.11

3.14

1.7

1.4

1562.71

2853.26

e6/l

0.56

Other maltreatment syndromes

2.64

3.14

2.1

1.4

3447.50

2064.79

e6/l

—

Bipolar affective disorders

596

1.48

3.14

1.3

1.4

11304.71

3814.65

e6/l

0.62

412

Assault by unspecified means

3.46

3.11

1.8

1.4

1110.71

2564.23

e6/l

—

Other blood glucose lowering drugs, excl. Insulins

142

1051

1.36

3.10

1.6

1.5

1212.23

2348.96

e6/l

2.34

107

753

Vitamin D deficiency

2.83

3.10

1.2

1.3

816.89

2739.18

e6/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

2.35

3.09

1.3

1.5

2793.50

1987.53

e6/l

0.23

Hepatocellular carcinoma

112

2.17

3.08

2.2

1.4

1853.82

1463.68

e6/l

0.13

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

626

4219

1.16

3.08

1.5

1.4

3319.92

3352.31

e6/l

0.01

434

2963

Other chondrocalcinosis

2.49

3.08

1.3

1.4

755.67

1668.57

e6/l

1.18

330

2329

1.22

3.08

1.3

1.5

3557.26

2553.28

e6/l

0.21

236

1653

Acute alcohol intoxication, ICD10

133

975

1.37

3.07

1.4

1.5

8341.49

3345.93

e6/l

0.51

668

Infections with a predominantly sexual mode of transmission

117

837

1.40

3.07

1.4

3136.94

3590.31

e6/l

0.13

579

Congenital malformations of the respiratory system

2.72

3.07

1.8

1.4

3003.80

1687.50

e6/l

—

Dermatitis and eczema

807

4201

1.14

3.06

1.5

1.4

3614.81

3271.50

e6/l

0.15

588

2934

Other diseases of biliary tract

496

1.52

3.03

1.4

4226.25

3936.41

e6/l

0.04

347

Delivery, wide proxy

112

830

0.71

3.03

1.4

1745.76

4201.77

e6/l

1.45

587

Acute generalized exanthematous pustulosis

182

1.88

3.01

1.7

1.3

1566.44

1700.37

e6/l

0.09

123

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS